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Introduction {#brb3497-sec-0005}
============

Anxiety disorders -- defined by excess worry, hyperarousal, and fear that is counterproductive and debilitating -- are some of the most common psychiatric conditions in the Western world (Simpson et al. [2010](#brb3497-bib-0046){ref-type="ref"}). The prevalence of anxiety disorders in the United States is estimated to be 18% (Kessler et al. [2005](#brb3497-bib-0028){ref-type="ref"}), and their annual cost is reported to be \$42.3 billion (Greenberg et al. [1999](#brb3497-bib-0501){ref-type="ref"}). In the European Union (EU), over 60 million people are affected by anxiety disorders in a given year, making them the most prevalent psychiatric conditions in the EU (Wittchen et al. [2011](#brb3497-bib-0060){ref-type="ref"}). The Global Burden of Disease (GBD) study estimated that anxiety disorders contributed to 26.8 million disability adjusted life years in 2010. (Whiteford et al. [2013](#brb3497-bib-0059){ref-type="ref"}). While a number of reviews have focused on the burden of depression and its economic, social, and health care policy implications, substantially fewer have assessed anxiety.

The past decade has seen increased research interest into anxiety disorders, in large part because of a greater recognition of their burden and the implications associated with untreated illness. Clinical reviews have shown that the presence of an anxiety disorder is a risk factor for the development of other anxiety and mood disorders and substance abuse. In clinical and population‐based studies, the development of comorbidities makes the treatment of primary and secondary disorders difficult, contributes to low remission rates, poor prognosis and risk of suicide (Nutt and Ballenger [2003](#brb3497-bib-0041){ref-type="ref"}; Simpson et al. [2010](#brb3497-bib-0046){ref-type="ref"}). Untreated anxiety has been associated with significant personal and societal costs, related to frequent primary and acute care visits, decreased work productivity, unemployment, and impaired social relationships (Simpson et al. [2010](#brb3497-bib-0046){ref-type="ref"}).

A number of primary studies on the prevalence of anxiety have been undertaken, but the variability in findings has made generalizability to the wider population difficult. This variability mainly results from differences in study setting (i.e., culture; clinical vs. population‐based), age and sex composition of samples, length of follow‐up, methods of anxiety assessment, and caseness criteria (i.e., types and number of disorders examined). Systematic reviews on the prevalence of these conditions in highly select, homogeneous population subgroups have been undertaken, but the selective citation of such estimates presents a distorted view of the overall burden of anxiety and limits generalizability.

The aim of this systematic review of reviews was to provide a comprehensive synthesis and description of the prevalence of anxiety disorders in the general population, as well as in clinical outpatient and inpatient groups affected by a range of chronic physical diseases and psychiatric disorders, as reported by individual reviews. Individuals recruited from the community can have different risk factor profiles than those sampled from clinical settings, potentially giving rise to different rates of mental health problems amongst these groups (Nutt and Ballenger [2003](#brb3497-bib-0041){ref-type="ref"}; Simpson et al. [2010](#brb3497-bib-0046){ref-type="ref"}). As a result, the burden needs to be assessed across different settings and segments of the population. To provide insight into the demographic groups that are most affected, we reported on estimates for men and women and different age groups, if this information was available. Since a number of studies (Walters et al. [2004](#brb3497-bib-0057){ref-type="ref"}; Skapinakis et al. [2005](#brb3497-bib-0047){ref-type="ref"}; Simpson et al. [2010](#brb3497-bib-0046){ref-type="ref"}) have identified the need to better understand the geographical variation of mental health problems, we included reviews that captured studies conducted across the globe at national and subnational levels. To provide insight into the chronicity of anxiety disorders, we provided period (i.e., 12‐month) and lifetime prevalence estimates. If the duration criterion was not clearly stated or the "point" or "current" prevalence was indicated, we simply referred to these estimates as "prevalence".

Findings from this systematic review will shed light on the groups that are most affected by anxiety disorders, and can be used to inform targeted screening and treatment efforts. This will be important in the planning of health services and the development of evidence‐based policy. Finally, results from this review can be used to identify areas where further research is needed.

This is the first study to provide a comprehensive synthesis of the disparate findings from systematic reviews undertaken on the burden of anxiety across the globe and using a systematic approach.

Methods {#brb3497-sec-0006}
=======

Search strategy {#brb3497-sec-0007}
---------------

We defined a systematic review in accordance with the Cochrane Collaboration and the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) Statement (Moher et al. [2009](#brb3497-bib-0037){ref-type="ref"}). (Appendix [1](#brb3497-app-0001){ref-type="app"}) We included high‐quality reviews that reported the prevalence of anxiety disorders in the general population or clinic‐based settings. We searched for reviews on young, middle‐aged, and older adults with risk behaviors (i.e., drug abuse), chronic or infectious diseases, psychiatric conditions, who are vulnerable, and living in countries across the globe. Reviews on the treatment of anxiety were not included, as we consider this to be a separate review topic that would merit an in‐depth analysis.

To identify reviews meeting the inclusion criteria, we searched Medline (inception‐May, 2015), PsycInfo (1987‐May, 2015), and Embase (inception‐May, 2015) using combinations of keywords relating to anxiety and prevalence (Appendix [2](#brb3497-app-0002){ref-type="app"}). Reference lists were hand‐searched for additional reviews. Titles and abstracts of non‐English language articles were translated to assess relevance. We excluded unpublished data. The review protocol is registered on PROSPERO (Remes et al. [2014](#brb3497-bib-0042){ref-type="ref"}).

Inclusion criteria {#brb3497-sec-0008}
------------------

We searched for reviews that reported the lifetime, period, or point prevalence (or simply "prevalence") of generalized anxiety disorder (GAD), obsessive‐compulsive disorder (OCD), social anxiety disorder (SAD) or social phobia, agoraphobia, panic disorder (PD) with or without agoraphobia, and simple or specific phobia, and anxiety not otherwise specified (NOS). Studies that reported the prevalence of aggregated anxiety disorders, subthreshold disorders, or anxiety symptoms were also included. Reviews were included regardless of the sampling framework used in primary studies.

Reviews were included regardless of the method of anxiety assessment. Specifically, reviews capturing primary studies on threshold and subthreshold disorders that were assessed through fully, semi‐, or unstructured interviews administered by clinicians or trained professionals, symptom checklists, clinician diagnoses, and self‐report were accepted. Interviews or self‐reported questionnaires that mapped to standard classificatory systems, such as the Diagnostic and Statistical Manual of Mental Disorders (DSM) (American Psychiatric Association, [2010](#brb3497-bib-0001){ref-type="ref"}) or the International Classification of Diseases (ICD) (World Health Organization, [2016](#brb3497-bib-0061){ref-type="ref"}), were also included.

OR and LL screened titles and abstracts, and disagreements were resolved through discussion. Dissertations, case reports, letters, and commentaries were excluded. Full‐text articles were retrieved for further assessment by OR.

Quality assessment {#brb3497-sec-0009}
------------------

Quality assessment of the reviews meeting the inclusion criteria was undertaken by OR and RvdL. If reviews met at least five of the criteria stipulated by AMSTAR (Shea et al. [2009](#brb3497-bib-0045){ref-type="ref"}), a validated measurement tool for assessing the quality of systematic reviews, they were included. For example, some of the AMSTAR quality criteria assess whether an "*a priori*" design was established, whether there was duplicate study selection and data extraction, if the literature search was comprehensive, whether the quality of primary studies was examined, etc.

Data extraction and analysis {#brb3497-sec-0010}
----------------------------

Data extraction was performed by OR and RvdL using the standardized form capturing device: the dates of publication and literature search; objectives; number of studies reviewed; prevalence of anxiety; sample characteristics; sample size range of primary studies; recommendations for future research, and limitations of primary studies and review. Disagreements were resolved through discussion.

Studies were grouped according to five common themes and prevalence was described in the context of: (1) addiction, (2) other mental and neurological disorders, (3) chronic physical diseases, (4) trauma, and (5) vulnerable population subgroups. If there were fewer than three reviews on a chronic physical disease, it was grouped under: "other chronic physical diseases" or "other chronic physical diseases in end‐stage". Vulnerable population subgroups refer to individuals at high risk for poor health, who may experience stigma, marginalization, or health service access barriers.

We did not perform a meta‐analysis because of the heterogeneity in study methodology. Quantitative measurement of heterogeneity was not undertaken. Finally, a meta‐analysis of primary studies included in 48 systematic reviews would not have been feasible. We described the prevalence of individual and aggregate anxiety disorders, subthreshold disorders, or symptoms of anxiety, as reported by the systematic reviews. If reviews provided clear prevalence estimates for men and women and different age groups, we also included this information.

Results {#brb3497-sec-0011}
=======

The search identified 1232 reviews on anxiety. After 338 duplicates were removed, titles and abstracts were screened, and the full text of 198 articles was retrieved. In total, 46 systematic reviews met the inclusion criteria (Fig. [1](#brb3497-fig-0001){ref-type="fig"}). Reference searches identified two additional reviews as relevant, yielding a total of 48 reviews in this systematic review (Appendix [3](#brb3497-app-0003){ref-type="app"}).

![Flowchart of main search strategy and article selection for systematic review of reviews.](BRB3-6-e00497-g001){#brb3497-fig-0001}

Of the 48 reviews, seven focused on the descriptive epidemiology of anxiety disorders, while five reviewed anxiety in relation to addiction. Four focused on mental and neurological disorders. A total of 19 reviews assessed anxiety in the context of chronic physical diseases: most of these focused on CVD (*n* = 6) and cancer (*n* = 7), followed by respiratory disease (*n* = 3) and diabetes (*n* = 3); the rest examined end‐stage physical disease (*n* = 4), and conditions that have been less commonly studied in the anxiety field (*n* = 4). Three reviews examined anxiety in the context of trauma, and ten focused on vulnerable population subgroups. Most of the reviews included international studies.

The global distribution of anxiety disorders {#brb3497-sec-0012}
--------------------------------------------

Seven reviews focused on the descriptive epidemiology of anxiety disorders, presenting age‐, sex‐, and time trends. In one international review (Somers et al. [2006](#brb3497-bib-0051){ref-type="ref"}), the pooled one‐year and lifetime prevalence of total anxiety disorders was estimated to be 10.6% (95% CI: 7.5%, 14.3%) and 16.6% (95% CI: 12.7%, 21.1%), respectively. Given the health care policy and service planning implications of high estimates, a high‐quality meta‐analysis (Baxter et al. [2014](#brb3497-bib-0006){ref-type="ref"}) investigated whether the age‐standardized point prevalence of anxiety increased over the last decade. Studies on cultures across the globe were reviewed and findings showed that the prevalence in 1990 (3.8% \[95% CI: 3.6%, 4.1%\] was very similar to that in 2005 and 2010 (4.0% \[95% CI: 3.7%, 4.2%\]). A sharp rise in younger people over time was noted, but changing age and population structures were hypothesized to be the drivers of this. Prevalence was found to be lowest in East Asia (2.8% \[95% CI: 2.2%, 3.4%\]) and highest in North America (7.7% \[95% CI: 6.8%, 8.8%\]) and the North African/Middle Eastern region (7.7% \[95% CI: 6.0%, 10%\]) (Baxter et al. [2014](#brb3497-bib-0006){ref-type="ref"}). A less rigorous review (Somers et al. [2006](#brb3497-bib-0051){ref-type="ref"}) estimated the highest lifetime prevalence of anxiety disorders in Swiss and US populations (23--28.7%), and the lowest in studies on Korea (9.2%). In Pakistan (Mirza and Jenkins [2004](#brb3497-bib-0034){ref-type="ref"}), the prevalence of total anxiety ranged from 1.76% to 25%, while a meta‐analysis on Germany (Vehling et al. [2012](#brb3497-bib-0055){ref-type="ref"}) reported it to be 13.5% (95% CI: 7.1%, 24.3%).

Women are almost twice as likely to be affected as men (female:male ratio of 1.9:1), with sex differences persisting over time and across high and low resource settings (Somers et al. [2006](#brb3497-bib-0051){ref-type="ref"}; Baxter et al. [2013](#brb3497-bib-0005){ref-type="ref"}; Steel et al. [2014](#brb3497-bib-0052){ref-type="ref"}). Irrespective of culture, individuals under the age of 35 years are disproportionately affected by anxiety disorders (Baxter et al. [2013](#brb3497-bib-0005){ref-type="ref"}, [2014](#brb3497-bib-0006){ref-type="ref"}) with the exception of Pakistan, where midlife represents a period of high burden (Mirza and Jenkins [2004](#brb3497-bib-0034){ref-type="ref"}).

Globally, specific phobia (4.9% \[95% CI: 3.4%, 6.8%\] and GAD (6.2% (95% CI: 4.0%, 9.2%) appear to have the highest lifetime prevalence, and panic disorder the lowest (1.2% \[95% CI: 95% CI: 0.7%, 1.9%\]) (Somers et al. [2006](#brb3497-bib-0051){ref-type="ref"}). In Germany, however, specific phobia (5.2%, \[95%CI: 3.3%, 8.2%\]) and GAD (3.7%, \[95% CI: 2.3%, 6.0%\]) are reported to be the most prevalent anxiety disorders (Vehling et al. [2012](#brb3497-bib-0055){ref-type="ref"}). In addition to geographical variation, caseness criteria are an important consideration when comparing estimates. One review reported an almost twofold higher prevalence of subthreshold GAD when the duration criterion was relaxed from 3 to 1 month (3.6% vs. 6.1%). In this review, older age groups showed the lowest estimates of past‐year subthreshold GAD (3%) (Haller et al. [2014](#brb3497-bib-0024){ref-type="ref"}).

Addiction {#brb3497-sec-0013}
---------

Five reviews focused on anxiety experienced in relation to addictive behaviors, including substance misuse, pathological gambling, and compulsive internet use. A global review on nonmedical prescription opioid use (NMPOU) reported the overall lifetime anxiety prevalence in patients at admissions or in treatment for substance abuse problems to range from 2% to 67% (Fatseas et al. [2010](#brb3497-bib-0016){ref-type="ref"}). While the prevalence of anxiety diagnoses is reportedly high at 29% (95% CI: 14%, 44%), that of subthreshold anxiety is higher still, with half of NMPOU populations enrolled in substance abuse treatment in North America reporting symptoms (50% \[95% CI: 16%, 84%\]) (Goldner et al. [2014](#brb3497-bib-0021){ref-type="ref"}). In contrast, general population samples of NMPOU in North America show a substantially lower prevalence of anxiety (16% \[95% CI: 1%, 30%\]) (Fischer et al. [2012](#brb3497-bib-0018){ref-type="ref"}). No significant age or sex‐effects were found in NMPOU groups enrolled in substance use treatment (Goldner et al. [2014](#brb3497-bib-0021){ref-type="ref"}).

Two other risk behaviors that have received attention in the addiction field include problem and pathological gambling, and more recently, internet addiction. When a global meta‐analysis assessed 11 community samples of pathological gamblers, the prevalence of anxiety disorders was reported to be 37.4% (Lorains et al. [2011](#brb3497-bib-0031){ref-type="ref"}). The prevalence of anxiety in the context of internet addiction is lower and comes mostly from studies conducted in Asian countries. A meta‐analysis found the prevalence of anxiety to be over two times higher in community samples of people with Internet addiction compared to control subjects (23.3% \[95% CI: 14.8, 34.8%\] vs 10.3% \[95% CI: 5.0, 19.9%\]), with those under the age of 39 being most affected (Ho et al. [2014](#brb3497-bib-0026){ref-type="ref"}).

Other mental and neurological disorders {#brb3497-sec-0014}
---------------------------------------

In Europe, approximately 13--28% of people with bipolar disorder recruited from clinical and community settings have comorbid anxiety, with GAD and panic disorder being frequently experienced by this population (Fajutrao et al. [2009](#brb3497-bib-0015){ref-type="ref"}). In the US and Italian samples with bipolar disorder (Amerio et al. [2014](#brb3497-bib-0002){ref-type="ref"}), OCD is also common. The prevalence of this anxiety disorder in those who are bipolar has been shown to range from 11.1% to 21% in population‐based studies, and 1.8% to 35.1% in clinical samples.

OCD is also highly comorbid with schizophrenia. A global review (Swets et al. [2014](#brb3497-bib-0053){ref-type="ref"}) estimated the prevalence of this disorder in people diagnosed with schizophrenia to be 12.3% (95% CI: 9.7%, 15.4%). The prevalence of obsessive compulsive symptoms (OCS) not meeting full caseness criteria was over twice that of OCD (30.7% \[95% CI: 23%, 39.6%\]). Lower anxiety prevalence was linked to sub‐Saharan African origin. Age and sex did not influence OCD or OCS rates (Swets et al. [2014](#brb3497-bib-0053){ref-type="ref"}). These estimates were mainly based on groups from clinical settings.

One of the highest prevalence figures of psychopathology was found by a review on multiple sclerosis (MS) (Marrie et al. [2015](#brb3497-bib-0032){ref-type="ref"}), which reported that almost 32% of people with MS have an anxiety disorder and over half experience symptoms. Some of the primary studies included in this review were based on participants recruited from the general population, suggesting that men and women with MS are at high risk for psychopathology. Health anxiety may be an important issue in this population subgroup, given that 26.4% of those with MS are affected. Study methodology made a significant contribution to the figures reported. Estimates of anxiety prevalence were substantially higher if they were derived through self‐reported questionnaires (25.5% \[95% CI: 16.7%, 34.3%\]) compared to administrative databases or medical records (15.4%, \[95% CI: 0%, 39.0%\]) (Marrie et al. [2015](#brb3497-bib-0032){ref-type="ref"}).

Chronic physical diseases {#brb3497-sec-0015}
-------------------------

### Cardiovascular disease {#brb3497-sec-0016}

Six reviews reported the prevalence of anxiety in the context of cardiovascular disease (CVD). Approximately a tenth of patients with cardiovascular disease and living in Western countries are affected by GAD (10.94% \[95% CI: 7.8%, 14.0%\] (Tully and Cosh [2013](#brb3497-bib-0054){ref-type="ref"}), with women showing higher anxiety levels than men (Clarke and Currie [2009](#brb3497-bib-0010){ref-type="ref"}). Anxiety symptom prevalence among patients with congestive heart failure is 2--49% (Janssen et al. [2008](#brb3497-bib-0027){ref-type="ref"}), and in end‐stage patients suffering from heart disease, it is 49% (Solano et al. [2006](#brb3497-bib-0050){ref-type="ref"}). Further, panic disorder is a common diagnosis in patients with coronary artery disease, with the prevalence ranging from 10% to 50% in this subgroup (Clarke and Currie [2009](#brb3497-bib-0010){ref-type="ref"}).

Individuals with noncardiac or nonspecific chest pain presenting to emergency departments, particularly women and those who are younger, appear to be disproportionately affected by anxiety. Compared to those with a determined cause of chest pain, anxiety prevalence was found to be higher in those with unknown etiology (21--53.5% of noncardiac chest pain patients have probable anxiety) (Webster et al. [2012](#brb3497-bib-0058){ref-type="ref"}).

A high‐quality, global meta‐analysis of population‐, hospital‐, and rehabilitation‐based studies found the prevalence of anxiety disorders in stroke patients to vary between 18% (95% CI: 8%, 29%) and 25% (95% CI: 21%, 28%) when measured by clinical interview and rating scales, respectively (Campbell Burton et al. [2013](#brb3497-bib-0008){ref-type="ref"}). Age and sex did not influence the probability of having anxiety after stroke in most of the included studies. GAD and phobic disorders were the commonest anxiety disorders post‐stroke.

### Cancer {#brb3497-sec-0017}

Seven reviews assessed anxiety among individuals diagnosed with or receiving treatment for cancer and in spouses of cancer patients. The prevalence of anxiety among cancer patients varies between 15% and 23%, with symptoms rising to 69--79% in the later stages of disease. There was no reported evidence with respect to age and sex (Solano et al. [2006](#brb3497-bib-0050){ref-type="ref"}; Clarke and Currie [2009](#brb3497-bib-0010){ref-type="ref"}).

A meta‐analysis (Yang et al. [2013](#brb3497-bib-0062){ref-type="ref"}) on working‐age and older adults living in Mainland China showed that the overall prevalence of anxiety in individuals with a cancer diagnosis was higher than that in noncancer controls (49.7% \[95%CI: 20.0%, 89.1%\] and 17.5%, respectively). Among German patients with breast cancer, the prevalence of anxiety was comparatively lower than in Chinese patients, ranging from 28.0% to 33.0% (Vehling et al. [2012](#brb3497-bib-0055){ref-type="ref"}).

Randomized controlled trials (RCT) and non‐RCT studies conducted across the globe showed that approximately a fourth to over half of individuals undergoing or who had undergone breast cancer treatment experienced anxiety (Lim et al. [2011](#brb3497-bib-0030){ref-type="ref"}). Lower levels of anxiety were observed in patients undergoing radiotherapy rather than chemotherapy. During chemotherapy, young age and high trait anxiety measured before infusions were correlated with the intensity of anxiety experienced (Lim et al. [2011](#brb3497-bib-0030){ref-type="ref"}). Among ovarian cancer patients, younger age groups were also disproportionately affected by anxiety. Following treatment for ovarian cancer, psychopathology tended to persist, with almost half (47%) of individuals experiencing anxiety symptoms at three months post‐treatment (Arden‐Close et al. [2008](#brb3497-bib-0004){ref-type="ref"}).

Long‐term cancer survivors and their spouses also experience elevated levels of anxiety. In a global meta‐analysis of outpatient clinic, hospital, and population‐based samples (Mitchell et al. [2013](#brb3497-bib-0036){ref-type="ref"}), the prevalence of anxiety in individuals who had been diagnosed with cancer at least 2 years previously was found to be much higher than in healthy controls (17.9% \[95% CI: 12.8%, 23.6%\] and 13.9% \[95% CI: 9.8%, 18.5%\], respectively). Further, almost half (40.1% \[95% CI: 25.4%, 55.9%\]) of spouses of long‐term cancer survivors developed anxiety. No age or sex effects were reported.

### Respiratory disease {#brb3497-sec-0018}

Three reviews focusing on anxiety in the context of respiratory disease indicated that the prevalence of anxiety was high among adults with COPD (32--57%) (Janssen et al. [2008](#brb3497-bib-0027){ref-type="ref"}), and higher still among those with far‐advanced, end‐stage respiratory disease (51--75%) (Solano et al. [2006](#brb3497-bib-0050){ref-type="ref"}). Among acute lung injury/acute respiratory distress syndrome (ALI/ARDS) survivors discharged from intensive care units in the United States and Germany, anxiety levels ranged from 23% to 48% (Davydow et al. [2008](#brb3497-bib-0012){ref-type="ref"}). No age or sex effects were reported.

### Diabetes {#brb3497-sec-0019}

Three systematic reviews assessed anxiety in adults with diabetes. One high‐quality global review of mostly North American and European studies (Smith et al. [2013](#brb3497-bib-0048){ref-type="ref"}) showed that the prevalence is significantly elevated in those with diabetes compared to other groups, but is also dependant on caseness criteria. Approximately 15% to 73% of people with diabetes have anxiety symptoms not meeting threshold criteria (vs. 19.9% to 43.1% of nondiabetic individuals), while 1.4% to 15.6% of people with diabetes meet threshold criteria for an anxiety disorder (vs. 1.6% to 8.8% of nondiabetic individuals). In another review capturing studies predominantly conducted in primary care or clinical settings, women with diabetes were found to have an almost two‐fold higher prevalence of anxiety than men with diabetes (55.3% and 32.9%) (Grigsby et al. [2002](#brb3497-bib-0023){ref-type="ref"}). Age effects were not reported. The anxiety disorders that are most common in the context of diabetes are anxiety not otherwise specified, specific phobia, GAD, and social phobia (Grigsby et al. [2002](#brb3497-bib-0023){ref-type="ref"}; Clarke and Currie [2009](#brb3497-bib-0010){ref-type="ref"}).

### Other chronic physical diseases {#brb3497-sec-0020}

Four reviews assessed anxiety in population subgroups with polycystic ovary syndrome (PCOS), benign joint hypermobility syndrome, musculoskeletal pain, and age‐related macular degeneration. Clinical, mostly Western samples of women with polycystic ovary syndrome (PCOS) had a much higher prevalence of generalized anxiety symptoms than control groups (20.4% and 3.9%, respectively) (Dokras et al. [2012](#brb3497-bib-0014){ref-type="ref"}). There is some evidence that social phobia and OCD are comorbid with PCOS. Differences in anxiety levels according to age were not found (Dokras et al. [2012](#brb3497-bib-0014){ref-type="ref"}).

Widely varying anxiety prevalence figures have been reported for Mediterranean populations with benign joint hypermobility syndrome (BJHS) (5--68%) (Smith et al. [2014](#brb3497-bib-0049){ref-type="ref"}), as well as for Western populations with musculoskeletal pain (0--20.9%) (Andersen et al. [2014](#brb3497-bib-0003){ref-type="ref"}). In relation to the latter group, the link between fibromyalgia and anxiety appears to be particularly strong. In people with BJHS, commonly occurring comorbidities are agoraphobia and panic disorder (Smith et al. [2014](#brb3497-bib-0049){ref-type="ref"}). The only chronic condition that has failed to show a link with anxiety is age‐related macular degeneration; while this review recruited patients from clinics, it was largely based on US studies (Dawson et al. [2014](#brb3497-bib-0013){ref-type="ref"}).

### Other chronic physical diseases in end‐stage {#brb3497-sec-0021}

Four reviews assessed anxiety in end‐stage conditions. A global meta‐analysis of mostly Western studies (Mitchell et al. [2011](#brb3497-bib-0035){ref-type="ref"}) estimated the pooled prevalence of anxiety disorders in palliative cancer patients to be 9.8% (95% CI: 6.8%, 13.2%). Estimates appear to vary widely by condition. Among patients with chronic renal failure, the prevalence of anxiety symptoms was found to be 25% in the terminal stage (Janssen et al. [2008](#brb3497-bib-0027){ref-type="ref"}), whereas another review found a prevalence of 38% in patients with end‐stage renal disease (Murtagh et al. [2007](#brb3497-bib-0040){ref-type="ref"}). Although patients suffering from end‐stage AIDS showed a high symptom prevalence of 8--34%, the highest estimates were found for end‐stage COPD (51--75%) and cancer patients (13--79%) (Solano et al. [2006](#brb3497-bib-0050){ref-type="ref"}). No associations between age or sex and anxiety were found in palliative‐care settings (Mitchell et al. [2011](#brb3497-bib-0035){ref-type="ref"}).

Trauma {#brb3497-sec-0022}
------

Three reviews tackled the issue of anxiety in the context of trauma. The first was primarily based on findings from UK and US studies and focused on traumatic limb amputees, and included veterans that had served in Vietnam, Iraq and Afghanistan (Mckechnie and John [2014](#brb3497-bib-0033){ref-type="ref"}). Very high prevalence figures were found, with anxiety affecting a fourth of traumatic limb amputees in some studies to over half in others. The second review was global in scope and assessed the frequency of lifetime anxiety among individuals with a history of sexual abuse (Chen et al. [2010](#brb3497-bib-0009){ref-type="ref"}). Widely varying anxiety estimates were reported by this review, ranging from 2% to 82%. Finally, a third review focused on GAD in refugees resident in high‐income Western countries; over half of the refugees were from southeast Asia. This meta‐analysis estimated that 4% of refugees experience GAD (Fazel et al. [2005](#brb3497-bib-0017){ref-type="ref"}). No age or sex effects in relation to anxiety disorders were reported.

Vulnerable population subgroups {#brb3497-sec-0023}
-------------------------------

### Older people and their caregivers {#brb3497-sec-0024}

Five reviews assessed anxiety in older people and their caregivers. The prevalence of anxiety disorders in old age varies widely in community (1.2--14%) and clinical (1--28%) studies conducted mostly in European and North American settings. Estimates are even higher when anxiety symptoms are accounted for. GAD is the commonest anxiety disorder in old age, with the prevalence ranging from 1.3% to 4.7% (Bryant et al. [2008](#brb3497-bib-0007){ref-type="ref"}). A random‐effects model (Volkert et al. [2013](#brb3497-bib-0056){ref-type="ref"}) showed that specific phobia also occurs frequently in older samples living in the community, while agoraphobia is the rarest anxiety disorder (Bryant et al. [2008](#brb3497-bib-0007){ref-type="ref"}). Women are at higher risk for psychopathology than men (Bryant et al. [2008](#brb3497-bib-0007){ref-type="ref"}).

Older population subgroups with cognitive dysfunction and their caregivers are disproportionately affected by anxiety (Monastero et al. [2009](#brb3497-bib-0039){ref-type="ref"}). In older people with mild cognitive impairment (MCI), the prevalence of anxiety symptoms varies from 11% to 75% (Monastero et al. [2009](#brb3497-bib-0039){ref-type="ref"}; Yates et al. [2013](#brb3497-bib-0063){ref-type="ref"}). Caregivers of older people with cognitive impairment are also affected by anxiety (prevalence estimates of 3.7--76.5%), with women and younger caregivers showing elevated levels (Cooper et al. [2007](#brb3497-bib-0011){ref-type="ref"}; Bryant et al. [2008](#brb3497-bib-0007){ref-type="ref"}).

### Pregnant women {#brb3497-sec-0025}

Three reviews focused on pregnant women. A meta‐analysis of international studies (Russell et al. [2013](#brb3497-bib-0043){ref-type="ref"}) reported higher OCD prevalence in pregnant (2.07%, \[95% CI: 1.26%, 3.37%\]) and postpartum (up to 12 months) (2.43%, \[95% CI: 1.46%, 4.00%\]) women compared to the general population (1.08%, \[95%: 0.80%, 1.46%\]). Asia and Europe had the lowest prevalence of OCD across conditions, while the Middle East and Africa had the highest. In Ethiopian and Nigerian samples recruited from health clinics and the community (Sawyer et al. [2010](#brb3497-bib-0044){ref-type="ref"}), the prevalence of anxiety was found to be high during both the pre‐ and post‐natal periods (14.8% \[95% CI: 12.3%, 17.4%\] and 14.0% \[95% CI: 12.9%, 15.2%\], respectively), with younger women showing elevated anxiety compared to older women (Sawyer et al. [2010](#brb3497-bib-0044){ref-type="ref"}). There is also some evidence from UK and US studies that a high BMI may contribute to anxiety symptoms during pregnancy (Molyneaux et al. [2014](#brb3497-bib-0038){ref-type="ref"}).

### Individuals identifying as lesbian, gay or bisexual, and self‐harm patients {#brb3497-sec-0026}

Two reviews focused on (1) predominantly Western individuals living in the community and identifying as lesbian, gay or bisexual (LGB), and (2) self‐harm patients presenting to general hospitals in countries across the globe. In LBG men, anxiety prevalence was estimated to be 3--20%, while LGB women showed somewhat higher estimates, at 3--39% (King et al. [2008](#brb3497-bib-0029){ref-type="ref"}). In a global meta‐analysis of self‐harm patients presenting to hospitals, the prevalence of anxiety disorders was found to be 35% (95% CI: 21.9%, 48.6%). Age‐ and sex‐based differences were small, while rates of anxiety were highest in young and old age groups of self‐harm adults (Hawton et al. [2013](#brb3497-bib-0025){ref-type="ref"}). All non‐Western studies of self‐harm patients were based in Asia, while most of the Western studies were conducted in the United Kingdom.

Discussion {#brb3497-sec-0027}
==========

We have synthesized 48 reviews on prevalence studies conducted across the globe. This is the first review to undertake a comprehensive synthesis of the systematic reviews conducted to date on the prevalence of anxiety disorders. It provides a comprehensive, up‐to‐date summary of the state of knowledge in this area.

A number of studies within the reviews were conducted in North America (predominantly the United States) and Europe (Fazel et al. [2005](#brb3497-bib-0017){ref-type="ref"}; Cooper et al. [2007](#brb3497-bib-0011){ref-type="ref"}; Arden‐Close et al. [2008](#brb3497-bib-0004){ref-type="ref"}; Davydow et al. [2008](#brb3497-bib-0012){ref-type="ref"}; Fajutrao et al. [2009](#brb3497-bib-0015){ref-type="ref"}; Lorains et al. [2011](#brb3497-bib-0031){ref-type="ref"}; Mitchell et al. [2011](#brb3497-bib-0035){ref-type="ref"}; Fischer et al. [2012](#brb3497-bib-0018){ref-type="ref"}; Tully and Cosh [2013](#brb3497-bib-0054){ref-type="ref"}; Volkert et al. [2013](#brb3497-bib-0056){ref-type="ref"}; Amerio et al. [2014](#brb3497-bib-0002){ref-type="ref"}; Goldner et al. [2014](#brb3497-bib-0021){ref-type="ref"}; Haller et al. [2014](#brb3497-bib-0024){ref-type="ref"}; Mckechnie and John [2014](#brb3497-bib-0033){ref-type="ref"}; Molyneaux et al. [2014](#brb3497-bib-0038){ref-type="ref"}; Marrie et al. [2015](#brb3497-bib-0032){ref-type="ref"}), included clinical and general population samples (Mirza and Jenkins [2004](#brb3497-bib-0034){ref-type="ref"}; Bryant et al. [2008](#brb3497-bib-0007){ref-type="ref"}; Fajutrao et al. [2009](#brb3497-bib-0015){ref-type="ref"}; Monastero et al. [2009](#brb3497-bib-0039){ref-type="ref"}; Chen et al. [2010](#brb3497-bib-0009){ref-type="ref"}; Sawyer et al. [2010](#brb3497-bib-0044){ref-type="ref"}; Lim et al. [2011](#brb3497-bib-0030){ref-type="ref"}; Campbell Burton et al. [2013](#brb3497-bib-0008){ref-type="ref"}; Hawton et al. [2013](#brb3497-bib-0025){ref-type="ref"}; Mitchell et al. [2013](#brb3497-bib-0036){ref-type="ref"}; Russell et al. [2013](#brb3497-bib-0043){ref-type="ref"}; Yates et al. [2013](#brb3497-bib-0063){ref-type="ref"}; Amerio et al. [2014](#brb3497-bib-0002){ref-type="ref"}; Haller et al. [2014](#brb3497-bib-0024){ref-type="ref"}; Molyneaux et al. [2014](#brb3497-bib-0038){ref-type="ref"}), and used mainly DSM or ICD criteria to ascertain diagnoses (Fajutrao et al. [2009](#brb3497-bib-0015){ref-type="ref"}; Hawton et al. [2013](#brb3497-bib-0025){ref-type="ref"}; Mitchell et al. [2013](#brb3497-bib-0036){ref-type="ref"}; Amerio et al. [2014](#brb3497-bib-0002){ref-type="ref"}; Goldner et al. [2014](#brb3497-bib-0021){ref-type="ref"}; Mckechnie and John [2014](#brb3497-bib-0033){ref-type="ref"}; Baxter et al. 2013; Swets et al. [2014](#brb3497-bib-0053){ref-type="ref"}). Younger age groups (Arden‐Close et al. [2008](#brb3497-bib-0004){ref-type="ref"}; Sawyer et al. [2010](#brb3497-bib-0044){ref-type="ref"}; Lim et al. [2011](#brb3497-bib-0030){ref-type="ref"}; Webster et al. [2012](#brb3497-bib-0058){ref-type="ref"}; Hawton et al. [2013](#brb3497-bib-0025){ref-type="ref"}; Yates et al. [2013](#brb3497-bib-0063){ref-type="ref"}; Baxter et al. [2014](#brb3497-bib-0006){ref-type="ref"}; Haller et al. [2014](#brb3497-bib-0024){ref-type="ref"}; Ho et al. [2014](#brb3497-bib-0026){ref-type="ref"}; Baxter et al. [2013](#brb3497-bib-0005){ref-type="ref"}), women (Somers et al. [2006](#brb3497-bib-0051){ref-type="ref"}; Bryant et al. [2008](#brb3497-bib-0007){ref-type="ref"}; Clarke and Currie [2009](#brb3497-bib-0010){ref-type="ref"}; Webster et al. [2012](#brb3497-bib-0058){ref-type="ref"}; Baxter et al. [2013](#brb3497-bib-0005){ref-type="ref"}, [2014](#brb3497-bib-0006){ref-type="ref"}; Hawton et al. [2013](#brb3497-bib-0025){ref-type="ref"}; Yates et al. [2013](#brb3497-bib-0063){ref-type="ref"}; Haller et al. [2014](#brb3497-bib-0024){ref-type="ref"}; Steel et al. [2014](#brb3497-bib-0052){ref-type="ref"}), and people from North America and North Africa/Middle East (Somers et al. [2006](#brb3497-bib-0051){ref-type="ref"}; Baxter et al. [2014](#brb3497-bib-0006){ref-type="ref"}) showed the highest prevalence of anxiety. Estimates remained stable or declined with age (Somers et al. [2006](#brb3497-bib-0051){ref-type="ref"}; Baxter et al. [2013](#brb3497-bib-0005){ref-type="ref"}), and secular trends were not observed in relation to the prevalence of total anxiety 4 (Baxter et al. [2014](#brb3497-bib-0006){ref-type="ref"}).

Compared to healthy populations or control groups, prevalence was higher in individuals with chronic physical diseases (Mitchell et al. [2013](#brb3497-bib-0036){ref-type="ref"}; Yang et al. [2013](#brb3497-bib-0062){ref-type="ref"}), and the burden was particularly high in the end stage (Solano et al. [2006](#brb3497-bib-0050){ref-type="ref"}; Murtagh et al. [2007](#brb3497-bib-0040){ref-type="ref"}; Mitchell et al. [2011](#brb3497-bib-0035){ref-type="ref"}). Anxiety symptoms tended to persist post‐disease if present before disease onset (Sawyer et al. [2010](#brb3497-bib-0044){ref-type="ref"}), reflecting a chronic, unremitting pattern of psychopathology. Individuals exposed to trauma or who were vulnerable and at risk for stigma (Cooper et al. [2007](#brb3497-bib-0011){ref-type="ref"}; Bryant et al. [2008](#brb3497-bib-0007){ref-type="ref"}; King et al. [2008](#brb3497-bib-0029){ref-type="ref"}; Monastero et al. [2009](#brb3497-bib-0039){ref-type="ref"}; Sawyer et al. [2010](#brb3497-bib-0044){ref-type="ref"}; Hawton et al. [2013](#brb3497-bib-0025){ref-type="ref"}; Russell et al. [2013](#brb3497-bib-0043){ref-type="ref"}; Volkert et al. [2013](#brb3497-bib-0056){ref-type="ref"}; Yates et al. [2013](#brb3497-bib-0063){ref-type="ref"}; Molyneaux et al. [2014](#brb3497-bib-0038){ref-type="ref"}), such as older people with cognitive impairment (Yates et al. [2013](#brb3497-bib-0063){ref-type="ref"}), were also more likely to experience anxiety. Prevalence figures were heterogeneous, and this made comparison between studies difficult. Heterogeneity was driven by differences in caseness criteria and sampling methods. For example, a meta‐regression (Swets et al. [2014](#brb3497-bib-0053){ref-type="ref"}) that assessed the influence of instrument differences on OCD prevalence in the context of schizophrenia showed that the prevalence was higher with the use of the Yale‐Brown Obsessive Compulsive Scale (YBOCS)/Obsessive Compulsive Inventory (OCI) (Goodman et al. [1989](#brb3497-bib-0022){ref-type="ref"}; Foa et al. [1998](#brb3497-bib-0019){ref-type="ref"}) compared to other instruments. Also, the lower the threshold of the YBOCS, the higher the estimated prevalence. A range of methods was used to measure anxiety, such as, standardized, structured interviews administered by trained professionals, clinician diagnoses, symptom checklists, and self‐report. Some reviews attempted to handle the assessment of anxiety in alternative ways. For example, one review (Baxter et al. [2013](#brb3497-bib-0005){ref-type="ref"}) mapped estimates onto ICD or DSM diagnostic criteria and conducted a meta‐analysis to provide an aggregate measure of anxiety. Other reviews either did not attempt a meta‐analysis, or because of very large differences in sampling methods within primary studies, reported disaggregated estimates and ranges found in primary studies. Across reviews, higher prevalence figures were found when subthreshold disorders or symptoms were assessed (Bryant et al. [2008](#brb3497-bib-0007){ref-type="ref"}; Goldner et al. [2014](#brb3497-bib-0021){ref-type="ref"}; Haller et al. [2014](#brb3497-bib-0024){ref-type="ref"}; Swets et al. [2014](#brb3497-bib-0053){ref-type="ref"}; Marrie et al. [2015](#brb3497-bib-0032){ref-type="ref"}) and when lifetime rather than past‐year or current prevalence was estimated (Somers et al. [2006](#brb3497-bib-0051){ref-type="ref"}; Volkert et al. [2013](#brb3497-bib-0056){ref-type="ref"}). With the exception of one review (Monastero et al. [2009](#brb3497-bib-0039){ref-type="ref"}), authors did not account for the use of psychoactive prescription medicines, such as anxiolytics, which could influence the reporting of anxiety symptoms.

Reviews produced inflated prevalence estimates with the use of less robust methodologies. Within reviews, low and variable response rates across primary studies were identified as another limitation (Somers et al. [2006](#brb3497-bib-0051){ref-type="ref"}; Haller et al. [2014](#brb3497-bib-0024){ref-type="ref"}). In one review, response rates across studies ranged from 45.9% to 99.5% (Steel et al. [2014](#brb3497-bib-0052){ref-type="ref"}).

The areas that received the most attention in the anxiety field include addiction and chronic physical diseases (mainly cancer, CVD, and respiratory diseases), while anxiety disorders other than PTSD in the context of (1) trauma and (2) psychiatric or neurological conditions, such as internet addiction and multiple sclerosis, are relatively new and underresearched areas. Surprisingly, only one review (King et al. [2008](#brb3497-bib-0029){ref-type="ref"}) examined LGB groups, despite this population being at high risk for poor health (Fredriksen‐Goldsen et al. [2013](#brb3497-bib-0020){ref-type="ref"}). Authors of this review (King et al. [2008](#brb3497-bib-0029){ref-type="ref"}) called for further research to produce more refined and consistent definitions of LGB and the recruitment of more representative samples.

Although most of the reviews included in this systematic review were conducted in the last few years, the field of anxiety is rapidly gaining research interest. Some differences in findings and methodologies between older and more recent reviews were noted. For example, recent reviews are increasingly recognizing that early adulthood is the period with the highest peak in anxiety (Arden‐Close et al. [2008](#brb3497-bib-0004){ref-type="ref"}; Sawyer et al. [2010](#brb3497-bib-0044){ref-type="ref"}; Lim et al. [2011](#brb3497-bib-0030){ref-type="ref"}; Webster et al. [2012](#brb3497-bib-0058){ref-type="ref"}; Hawton et al. [2013](#brb3497-bib-0025){ref-type="ref"}; Yates et al. [2013](#brb3497-bib-0063){ref-type="ref"}; Baxter et al. [2014](#brb3497-bib-0006){ref-type="ref"}; Haller et al. [2014](#brb3497-bib-0024){ref-type="ref"}; Ho et al. [2014](#brb3497-bib-0026){ref-type="ref"}; Baxter et al. [2013](#brb3497-bib-0005){ref-type="ref"}), and the contexts within which psychopathology is assessed are expanding to a greater number of physical diseases and newly emergent disorders \[e.g. internet addiction (Ho et al. [2014](#brb3497-bib-0026){ref-type="ref"})\]. Also, newer research is starting to expand its scope to Asian countries (Yang et al. [2013](#brb3497-bib-0062){ref-type="ref"}; Ho et al. [2014](#brb3497-bib-0026){ref-type="ref"}), a previously identified limitation. More recent reviews are of higher quality, and have started considering instrument differences and their effects on prevalence estimates (Lorains et al. [2011](#brb3497-bib-0031){ref-type="ref"}; Swets et al. [2014](#brb3497-bib-0053){ref-type="ref"}), another previously identified limitation.

Recommendations for future research and clinical practice {#brb3497-sec-0028}
---------------------------------------------------------

Recommendations for future research were made by review authors, such as the use of longitudinal designs to address temporality issues (Murtagh et al. [2007](#brb3497-bib-0040){ref-type="ref"}; Arden‐Close et al. [2008](#brb3497-bib-0004){ref-type="ref"}; Bryant et al. [2008](#brb3497-bib-0007){ref-type="ref"}; Janssen et al. [2008](#brb3497-bib-0027){ref-type="ref"}; King et al. [2008](#brb3497-bib-0029){ref-type="ref"}; Clarke and Currie [2009](#brb3497-bib-0010){ref-type="ref"}; Sawyer et al. [2010](#brb3497-bib-0044){ref-type="ref"}; Dokras et al. [2012](#brb3497-bib-0014){ref-type="ref"}; Fischer et al. [2012](#brb3497-bib-0018){ref-type="ref"}; Webster et al. [2012](#brb3497-bib-0058){ref-type="ref"}; Russell et al. [2013](#brb3497-bib-0043){ref-type="ref"}; Smith et al. [2013](#brb3497-bib-0048){ref-type="ref"}; Goldner et al. [2014](#brb3497-bib-0021){ref-type="ref"}; Ho et al. [2014](#brb3497-bib-0026){ref-type="ref"}; Mckechnie and John [2014](#brb3497-bib-0033){ref-type="ref"}); population‐based research that is less susceptible to the help‐seeking/self‐selection bias often present in clinical studies (Grigsby et al. [2002](#brb3497-bib-0023){ref-type="ref"}; Murtagh et al. [2007](#brb3497-bib-0040){ref-type="ref"}); and the use of valid and reliable instruments and consistent approaches to examine anxiety levels pre‐ and post‐disease (Davydow et al. [2008](#brb3497-bib-0012){ref-type="ref"}; Monastero et al. [2009](#brb3497-bib-0039){ref-type="ref"}; Sawyer et al. [2010](#brb3497-bib-0044){ref-type="ref"}; Webster et al. [2012](#brb3497-bib-0058){ref-type="ref"}; Campbell Burton et al. [2013](#brb3497-bib-0008){ref-type="ref"}; Smith et al. [2013](#brb3497-bib-0048){ref-type="ref"}; Volkert et al. [2013](#brb3497-bib-0056){ref-type="ref"}; Goldner et al. [2014](#brb3497-bib-0021){ref-type="ref"}; Molyneaux et al. [2014](#brb3497-bib-0038){ref-type="ref"}; Swets et al. [2014](#brb3497-bib-0053){ref-type="ref"}; Marrie et al. [2015](#brb3497-bib-0032){ref-type="ref"}). The measure of "total" or "any anxiety" is not clinically meaningful and is discouraged in favor of the assessment of individual disorders (Smith et al. [2013](#brb3497-bib-0048){ref-type="ref"}; Tully and Cosh [2013](#brb3497-bib-0054){ref-type="ref"}). Consensus on definitions used to define study samples (e.g., sexual orientation) (King et al. [2008](#brb3497-bib-0029){ref-type="ref"}; Fischer et al. [2012](#brb3497-bib-0018){ref-type="ref"}; Ho et al. [2014](#brb3497-bib-0026){ref-type="ref"}) and diagnostic standardization with respect to the measurement of psychiatric disorders were also emphasized (Monastero et al. [2009](#brb3497-bib-0039){ref-type="ref"}; Goldner et al. [2014](#brb3497-bib-0021){ref-type="ref"}; Swets et al. [2014](#brb3497-bib-0053){ref-type="ref"}), as well as research into the risk factors, illness trajectory, hereditary, and biological markers of anxiety (Somers et al. [2006](#brb3497-bib-0051){ref-type="ref"}; Davydow et al. [2008](#brb3497-bib-0012){ref-type="ref"}; Monastero et al. [2009](#brb3497-bib-0039){ref-type="ref"}; Chen et al. [2010](#brb3497-bib-0009){ref-type="ref"}; Dokras et al. [2012](#brb3497-bib-0014){ref-type="ref"}; Russell et al. [2013](#brb3497-bib-0043){ref-type="ref"}; Amerio et al. [2014](#brb3497-bib-0002){ref-type="ref"}; Ho et al. [2014](#brb3497-bib-0026){ref-type="ref"}; Smith et al. [2014](#brb3497-bib-0049){ref-type="ref"}), and the appropriateness of anxiety screening measures in the context of physical diseases and cultures around the world (who may express distress differently) (Fazel et al. [2005](#brb3497-bib-0017){ref-type="ref"}; Bryant et al. [2008](#brb3497-bib-0007){ref-type="ref"}; Sawyer et al. [2010](#brb3497-bib-0044){ref-type="ref"}; Baxter et al. [2013](#brb3497-bib-0005){ref-type="ref"}; Hawton et al. [2013](#brb3497-bib-0025){ref-type="ref"}; Steel et al. [2014](#brb3497-bib-0052){ref-type="ref"}). Research questions should be structured around theories (Arden‐Close et al. [2008](#brb3497-bib-0004){ref-type="ref"}; Webster et al. [2012](#brb3497-bib-0058){ref-type="ref"}). Recommendations were made for the inclusion of appropriate control subjects in studies to determine whether prevalence differs between exposed and comparison groups (Yang et al. [2013](#brb3497-bib-0062){ref-type="ref"}; Dawson et al. [2014](#brb3497-bib-0013){ref-type="ref"}). Finally, further treatment or intervention studies are needed to alleviate anxiety (Mirza and Jenkins [2004](#brb3497-bib-0034){ref-type="ref"}; Murtagh et al. [2007](#brb3497-bib-0040){ref-type="ref"}; Arden‐Close et al. [2008](#brb3497-bib-0004){ref-type="ref"}; Clarke and Currie [2009](#brb3497-bib-0010){ref-type="ref"}; Fatseas et al. [2010](#brb3497-bib-0016){ref-type="ref"}; Lim et al. [2011](#brb3497-bib-0030){ref-type="ref"}; Amerio et al. [2014](#brb3497-bib-0002){ref-type="ref"}; Goldner et al. [2014](#brb3497-bib-0021){ref-type="ref"}; Haller et al. [2014](#brb3497-bib-0024){ref-type="ref"}; Ho et al. [2014](#brb3497-bib-0026){ref-type="ref"}; Smith et al. [2014](#brb3497-bib-0049){ref-type="ref"}; Swets et al. [2014](#brb3497-bib-0053){ref-type="ref"}).

Clinical recommendations included the administration of targeted anxiety screening and, if necessary, treatment. For example, suggestions were made for the screening of substance users at treatment entry (Fatseas et al. [2010](#brb3497-bib-0016){ref-type="ref"}) or patients with noncardiac chest pain presenting to acute care (Webster et al. [2012](#brb3497-bib-0058){ref-type="ref"}). It was also shown that certain anxiety disorders were more common in certain groups, such as OCD in schizophrenia (Swets et al. [2014](#brb3497-bib-0053){ref-type="ref"}), PD and GAD in CVD (Campbell Burton et al. [2013](#brb3497-bib-0008){ref-type="ref"}), and SP in diabetes (Grigsby et al. [2002](#brb3497-bib-0023){ref-type="ref"}). Additional research on individual anxiety disorders is needed to confirm these findings, but once this is underway, further impetus will be provided for the targeted screening of high‐risk groups in relation to individual anxiety disorders.

This review has some limitations. Despite extensive database searches, it is possible that some reviews have been missed. Also, the high heterogeneity in anxiety assessment methods and sampling frameworks within primary studies contributed to large differences in prevalence estimates within and across reviews, making it difficult to draw conclusions about the burden of anxiety. Also, a number of the reviews were based on English‐language studies conducted in predominantly Western settings, making generalizability to other parts of the world difficult.

Conclusions {#brb3497-sec-0029}
===========

Anxiety disorders are increasingly being recognized as important determinants of poor health and major contributors to health service use across the globe (Nutt and Ballenger [2003](#brb3497-bib-0041){ref-type="ref"}; Simpson et al. [2010](#brb3497-bib-0046){ref-type="ref"}). Despite epidemiologic advances in this field, important areas of research remain under‐ or unexplored. There is a need for further studies on the prevalence of anxiety disorders in the context of: personality disorders; Indigenous cultures in Canada, the United States, New Zealand, and Australia; African, Middle Eastern, Eastern European, Asian and South American countries; and marginalized populations, such as injection drug users, street youth, and sex workers. These recommendations can serve to guide the research agenda, and most importantly, help develop tailored and timely interventions.
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exp Meta Analysis/((meta adj analy\$) or metaanalys\$).tw.(systematic adj (review\$1 or overview\$1)).tw.or/1--3cancerlit.ab.cochrane.ab.embase.ab.(psychlit or psyclit).ab.(psychinfo or psycinfo).ab.(cinahl or cinhal).ab.science citation index.ab.bids.ab.or/5--12reference lists.ab.bibliograph\$.ab.hand‐search\$.ab.manual search\$.ab.relevant journals.ab.or/14--18data extraction.ab.selection criteria.ab.20 or 21review.pt.22 and 23letter.pt.editorial.pt.animal/human/27 not (27 and 28)or/25--26, 294 or 13 or 19 or 2431 not 30anxiety/or generalized anxiety disorder/or anxiety disorder/prevalence.mp.32 and 33 and 34prevalen\*.mp. \[mp = title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer, device trade name, keyword\]32 and 33 and 36
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Meta‐Analysis as Topic/meta analy\$.tw.metaanaly\$.tw.Meta‐Analysis/(systematic adj (review\$1 or overview\$1)).tw.exp Review Literature as Topic/or/1--6cochrane.ab.embase.ab.(psychlit or psyclit).ab.(psychinfo or psycinfo).ab.(cinahl or cinhal).ab.science citation index.ab.bids.ab.cancerlit.ab.or/8--15reference list\$.ab.bibliograph\$.ab.hand‐search\$.ab.relevant journals.ab.manual search\$.ab.or/17--21selection criteria.ab.data extraction.ab.23 or 24Review/25 and 26Comment/Letter/Editorial/animal/human/31 not (31 and 32)or/28--30, 337 or 16 or 22 or 2735 not 34exp Anxiety/or exp Anxiety Disorders/36 and 37prevalence.mp.36 and 37 and 3937 and 3936 and 41prevalen\*.mp. \[mp = title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier\]36 and 37 and 43
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 {#brb3497-sec-0037}

###### 

Systematic reviews describing the prevalence of anxiety disorders

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Review details                                                              Population characteristics and sample size                                                                     Sampling methods                                                                                                                                                                                                                                                                                               Anxiety assessment methods                                                                                     Anxiety prevalence (prevalence %, \[95% CI\]) and summary of results
  --------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Global distribution of anxiety disorders**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Somers [2006](#brb3497-bib-0051){ref-type="ref"}\                           Adults\                                                                                                        Community surveys using probability sampling                                                                                                                                                                                                                                                                   Diagnostic criteria, standardized instruments or clinician diagnosis                                           Pooled one‐year and lifetime prevalence of:\
  *Search:* 2004\                                                             Range: 500--20,000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Total anxiety disorders: 10.6% (7.5, 14.3), 16.6% (12.7, 21.1)\
  *\# incl. studies* 39\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   PD: 1.0% (0.6, 1.5), 1.2% (0.7, 1.9)\
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Agoraphobia: 1.6% (1.0, 2.3), 3.1% (2.1, 4.4)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           SAD: 4.5% (3.0, 6.4), 2.5% (1.4, 4.0)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           SP: 3.0% (1.0, 5.8) and 4.9% (3.4, 6.8)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           OCD: 0.5% (0.3, 0.9), 1.3% (0.9, 1.8)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           GAD: 2.6% (1.4, 4.2), 6.2% (4.0, 9.2)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Anxiety higher in women\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           SAD rates decline with age\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Switzerland, US: 23--28.7; Korea: 9.2

  Baxter [2013](#brb3497-bib-0005){ref-type="ref"}\                           44 countries across the globe\                                                                                 Community samples                                                                                                                                                                                                                                                                                              Interview schedules, semi‐structured instruments, diagnostic instruments that mapped to DSM or ICD             Global prevalence: 7.3% (4.8--10.9)\
  *Search:* 2009\                                                             Median: 2419                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 5.3% (3.5, 8.1) in African & 10.4% (7.0, 15.5) in Euro/Anglo cultures\
  *\# incl. studies* 87\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Women 2× men; younger people more affected\
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Adults 55 + 20% less anxiety than 35--55\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           20--50% lower risk in cultures compared to Euro/Anglo

  Mirza [2004](#brb3497-bib-0034){ref-type="ref"}\                            Adults ages 18--65 years from community and clinical settings\                                                 Population‐based, community, primary care samples; patients presenting to traditional or faith healers; psychiatric outpatients or inpatients\                                                                                                                                                                 Psychiatric diagnoses, diagnoses made by trained workers using validated instruments                           Anxiety prevalence: 1.76--25%\
  *Search:* March 2002\                                                       Range: 113--2620                                                                                               Clinical and community settings in Pakistan                                                                                                                                                                                                                                                                                                                                                                                   Middle‐aged more affected
  *\# incl. studies:* 20\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Vehling [2012](#brb3497-bib-0055){ref-type="ref"}\                          Adults 38--73 years\                                                                                           Mostly US studies                                                                                                                                                                                                                                                                                              Structured clinical interviews                                                                                 4‐week prev. of anxiety disorders: 10.2% (6.9, 14.8) \[International & German\]; 13.5% (7.1, 24.3) \[German only\]\
  *Search: not rep.*\                                                         Sample size not rep.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Germans with breast cancer: anxiety 28--33%; SP 5.2% (3.3, 8.2) & GAD 3.7% (2.3, 6.0) common
  *\# incl. studies* 89\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Baxter [2014](#brb3497-bib-0006){ref-type="ref"}\                           DSM/ICD community studies on people, all ages; GHQ for studies on secular trends\                              Community‐based studies                                                                                                                                                                                                                                                                                        Surveys, diagnostic criteria                                                                                   Age‐standardized global point prev.: 3.8% (3.6--4.1%) in 1990; 4.0% (3.7--4.2%) in 2005 and 2010\
  *Search:* 2009\                                                             Range: 116--78,290                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Anxiety women:men ratio of 1.9:1\
  *\# incl. studies* 91\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Sharp rise in adolescents; highest prev. 15--35 years\
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Prev. lowest in East Asia \[2.8% (2.2--3.4%)\] and highest in North America & North Africa/Middle East \[7.7%, (6.8--8.8%) vs.7.7% (6.0--10%)\]

  Haller [2014](#brb3497-bib-0024){ref-type="ref"}\                           Pop‐based studies of subthreshold DSM/ICD GAD in adults 15--96 years\                                          General population and primary care sample\                                                                                                                                                                                                                                                                    Diagnostic criteria                                                                                            12‐month median prev. -- 3.9% (range: 2.1--6.6%)\
  *Search:* 2006\                                                             Range: 90--17,739                                                                                              Clinical and community settings\                                                                                                                                                                                                                                                                                                                                                                                              When GAD duration criterion relaxed, prev of subthreshold GAD increased: 12 month prev. with 3 +  mo. vs. 1 +  mo. duration: 3.6% vs. 6.1%\
  *\# incl. studies:* 18\                                                                                                                                                                    Mostly North American and European data                                                                                                                                                                                                                                                                                                                                                                                       Higher prev in younger people in clinical samples, but higher in older people in community (3%)\
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Median point prev. in primary care: 5.9% (1.3--8.3%)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Women higher prev than men\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           42% of young women with subthreshold GAD also had other subthreshold mental disorders\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Subthreshold GAD mostly comorbid with other anxiety disorders

  Steel [2014](#brb3497-bib-0052){ref-type="ref"}\                            26 high‐income and 37 LMIC countries\                                                                          Population sample; Census or probabilistic epidemiological procedures used in surveys\                                                                                                                                                                                                                                                                                                                                        Period prev of anxiety disorders in men 4.3% (3.7--4.9%), 8.7% (7.7--9.8%) in women\
  *Search:* Jan 2014\                                                         Mostly 16--65 years\                                                                                           Community settings                                                                                                                                                                                                                                                                                                                                                                                                            Lifetime prev of anxiety disorders in men 10.1% (8.8--11.6%), 18.2% (16.2--20.4%) in women\
  *\# incl. studies* 174\                                                     Samples of 450+ people\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Same pattern of gender differences in HIC and LMIC countries
  *Meta‐analysis:* yes                                                        Median n: 2314                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  **Addiction**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Fatseas [2010](#brb3497-bib-0016){ref-type="ref"}\                          All‐age participants with opiate dependence\                                                                   Clinical samples from drug treatment programs                                                                                                                                                                                                                                                                  Structured interviews and diagnostic criteria                                                                  Lifetime prev: 2--58% and 5--67%\
  *Search:* Jan. 2009\                                                        Range: 50--716                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               SP, SAD, GAD common\
  *\# incl. studies* 18\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Narrower prev with recent DSM criteria
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Fischer [2012](#brb3497-bib-0018){ref-type="ref"}\                          Adults\                                                                                                        General population samples\                                                                                                                                                                                                                                                                                    Standardized (clinical diagnostic) and nonstandardized indicators or symptoms                                  Symptoms prev in general pop: 16% (1--30)
  *Search:* Dec. 2011\                                                        Range: 1,086--166,453                                                                                          Community settings\                                                                                                                                                                                                                                                                                                                                                                                                           
  *\# incl. studies* 9\                                                                                                                                                                      All North American, mostly US studies                                                                                                                                                                                                                                                                                                                                                                                         
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Goldner [2014](#brb3497-bib-0021){ref-type="ref"}\                          Patients at admission or in treatment for substance abuse problems from US and Canada\                         Chart review of admissions and discharges, survey of people entering treatment programs\                                                                                                                                                                                                                       Clinical diagnostics based on DSM, other clinical assessments, or symptom self‐reports                         Prev of diagnosis and symptoms: 38% (14--63)\
  *Search:* April 2012\                                                       Sample size not rep.                                                                                           Clinical settings\                                                                                                                                                                                                                                                                                                                                                                                                            Diagnosis prev: 29 (14--44); symptoms: 50% (16--84)\
  *\# incl. studies* 11\                                                                                                                                                                     All North American, mostly US studies                                                                                                                                                                                                                                                                                                                                                                                         No significant age or sex‐effects
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Lorains [2011](#brb3497-bib-0031){ref-type="ref"}\                          Adults\                                                                                                        General population samples/surveys\                                                                                                                                                                                                                                                                            Validated screening tool/standardized measurement tools                                                        Prev: 37.4%
  *Search:* Sept. 2010\                                                       Range: 2417--43,093                                                                                            Community settings\                                                                                                                                                                                                                                                                                                                                                                                                           
  *\# incl. studies* 11\                                                                                                                                                                     Mostly US studies                                                                                                                                                                                                                                                                                                                                                                                                             
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Ho [2014](#brb3497-bib-0026){ref-type="ref"}\                               Age 10+\                                                                                                       Postal survey, students, respondents to ads\                                                                                                                                                                                                                                                                   Standard questionnaires, symptom checklists, interviews                                                        Prev of anxiety in IA patients vs normal controls: 23.3% (95% CI: 14.8--34.8) vs 10.3% (5.0--19.9)\
  *Search:* 2012\                                                             1641 patients with internet addition (IA) and 11,210 controls without IA                                       Community settings\                                                                                                                                                                                                                                                                                                                                                                                                           Anxiety most prev in young age groups with IA (19--39 years highest burden)
  *\# incl. studies* 8\                                                                                                                                                                      Mostly Asian samples                                                                                                                                                                                                                                                                                                                                                                                                          
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  **Other mental and neurological disorders**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Fajutrao [2009](#brb3497-bib-0015){ref-type="ref"}\                         Patients with bipolar disorder\                                                                                Surveys; general population, inpatients\                                                                                                                                                                                                                                                                       DSM diagnoses                                                                                                  13--28% of bipolar patients with anxiety\
  *Search:* past 10 years\                                                    Range: 72--1,631,462                                                                                           Clinical and community settings\                                                                                                                                                                                                                                                                                                                                                                                              GAD and PD common\
  *\# incl. studies* 26\                                                                                                                                                                     European studies                                                                                                                                                                                                                                                                                                                                                                                                              70%, 24%, 16% for Italy, France, Germany
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Amerio [2014](#brb3497-bib-0002){ref-type="ref"}\                           Pop‐based and hospital‐based studies on DSM OCD in bipolar disorder (BD), ages 6 + \                           Clinical and community settings\                                                                                                                                                                                                                                                                               Interviews, DSM criteria                                                                                       Pop‐based US, Italian studies: lifetime prev of OCD in BD: 11.1--21%\
  *Search:* Mar 2013\                                                         Range: 15--1416                                                                                                Most studies conducted in Europe and North America                                                                                                                                                                                                                                                                                                                                                                            Hospital‐based studies: lifetime prev: 1.8--35.1%\
  *\# incl. studies:* 64\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  OCD onset usually concomitant with first mood episode
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Swets [2014](#brb3497-bib-0053){ref-type="ref"}\                            Schizophrenia patients\                                                                                        Mainly clinical settings                                                                                                                                                                                                                                                                                       Interviews, symptom scales, DSM                                                                                Prev of OCD and OCS in schizo. -- 12.3% (9.7--15.4%) & 30.7% (23--39.6%); meta‐regression: prev of OCS: 30.3%\
  *Search:* Dec 2009\                                                         18--509                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Lower OCD prev: Sub‐Saharan African origin, recent onset schizo.\
  *\# incl. studies* 43\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Higher OCD prev: DSM‐IV and Y‐BOCS; after adjustment: OCD prev 13.6% (11.8--15.8%)\
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Higher prev with Y‐BOCS, OCI\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Prev of OCD/OCS in studies using YBOCS/OCI : 16.9% (13.25--21.1%) vs studies not using YBOCS/OCI: 8.0 (5.3--11.9%)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Higher the YBOCS threshold, lower OCS prev

  Marrie [2015](#brb3497-bib-0032){ref-type="ref"}\                           MS populations; all ages\                                                                                      Population‐based, possibly other sampling\                                                                                                                                                                                                                                                                     Structured diagnostic interviews, medical records review, self‐reported diagnoses, validated instruments       Prev. of anxiety disorders & symptoms in MS: 31.7% vs 63.4%; Higher anxiety in MS than in controls\
  *Search:* Nov. 2013\                                                        Range: not rep.                                                                                                Some studies conducted in community settings\                                                                                                                                                                                                                                                                                                                                                                                 Anxiety at MS symptom onset: 2.72% vs 6.23% at diagnosis; prev. of health anxiety in MS: 26.4%\
  *\# incl. studies* 118\                                                                                                                                                                    Most studies from Central or Western Europe or parts of North America                                                                                                                                                                                                                                                                                                                                                         Pop‐based studies -- anxiety prev: 21.9% (8.76--35.0%)\
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Anxiety prev questionnaires vs admin data/medical records: 25.5% (16.7--34.3) vs. 15.4% (0--39.0)

  **Chronic physical diseases**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  *Cardiovascular disease*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Janssen [2008](#brb3497-bib-0027){ref-type="ref"}\                          End‐of‐life CHF, COPD, CRF patients\                                                                           Proxies and patients recruited, chart/medical record review                                                                                                                                                                                                                                                                                                                                                                   CHF: 2--49% (anxiety prev)\
  *Search:* 2007\                                                             Mean age: 38--86\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            COPD: 32--57%\
  *\# incl. studies* 39\                                                      Sample size: not rep.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        CRF: 20--41%\
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      CRF terminal: 25%

  Solano [2006](#brb3497-bib-0050){ref-type="ref"}\                           Adults with advanced cancer, AIDS, heart disease, COPD, renal disease\                                         Medical records, interviews with patients' families, proxies used, prescriptions for psychotropic drugs\                                                                                                                                                                                                                                                                                                                      Prev of anxiety symptoms:\
  *Search:* June 2004\                                                        Range: 19--10,379                                                                                              Some studies conducted in clinical settings                                                                                                                                                                                                                                                                                                                                                                                   Cancer: 13--79%\
  *\# incl. studies* 64\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   AIDS: 8--34%\
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Heart disease: 49%\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           COPD: 51--75%\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Renal disease: 39--70%

  Tully [2013](#brb3497-bib-0054){ref-type="ref"}\                            Older people: median age: 60 years\                                                                            Primary care sample, CHD patients attending rehab, outpatient clinic, people going in for surgery\                                                                                                                                                                                                             Diagnostic interview tools                                                                                     GAD prevalence: 10.94% (7.8, 14.0)\
  *Search:* May 2011\                                                         Range: 86--1015                                                                                                Clinical studies\                                                                                                                                                                                                                                                                                                                                                                                                             Lifetime GAD: 25.8% (20.84, 30.8)
  *\# incl. studies* 12\                                                                                                                                                                     Mostly US studies                                                                                                                                                                                                                                                                                                                                                                                                             
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Clarke [2009](#brb3497-bib-0010){ref-type="ref"}\                           Sample size: not rep.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Heart disease -- PD: 10--50%\
  *Search:* May 2003\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Diabetes mellitus: 14% with GAD\
  *\# incl. studies* 159\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Cancer: 15--23%; more advanced stage: 69%\
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Arthritis and osteoporosis link to anxiety\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Women more anxiety than men (55.3% vs 32.9%)

  Webster [2012](#brb3497-bib-0058){ref-type="ref"}\                          Adults with (nonspecific) acute chest pain in acute care\                                                      Patients admitted to ED\                                                                                                                                                                                                                                                                                       Symptom checklists                                                                                             21--53.5% of NCCP patients had probable anxiety\
  *Search:* Nov. 2010\                                                        Range: 50--1300                                                                                                Clinical studies                                                                                                                                                                                                                                                                                                                                                                                                              Women and younger patients -- elevated anxiety\
  *\# incl. studies* 12\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Anxiety levels in NCCP similar to or higher than in CCP or healthy controls
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Campbell Burton [2013](#brb3497-bib-0008){ref-type="ref"}\                  Mean age: 66--71 years\                                                                                        Population‐based (all stroke patients recruited from particular geographical area), hospital‐ and rehabilitation‐based (inpatients or those attending rehab facilities), community‐based (did not attempt to capture all stroke cases in geographic area)\                                                     Anxiety symptom scales, clinical diagnoses, single question measure, researcher‐developed questions            Prev of anxiety disorders: 18% (8--29)\
  *Search:* March 2011\                                                       Range: 15--498                                                                                                 Clinical and community settings                                                                                                                                                                                                                                                                                                                                                                                               PD & GAD common\
  *\# incl. studies* 44\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Anxiety caseness (rating scales): 25% (21--28)\
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     1/3 of patients with post‐stroke anxiety had pre‐stroke mood or anxiety\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           High anxiety‐depression comorbidity

  *Cancer*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Clarke [2009](#brb3497-bib-0010){ref-type="ref"} -- previously described                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Solano [2006](#brb3497-bib-0050){ref-type="ref"} -- previously described                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Yang [2013](#brb3497-bib-0062){ref-type="ref"}\                             Adults 18 +  years from Mainland China\                                                                        Unclear (assessed "patients")\                                                                                                                                                                                                                                                                                 Clinical diagnosis, symptom checklists, self‐report questionnaires                                             Anxiety prev: 49.7% (range: 20--89.1) in cancer, and 17.50% in the noncancer control group
  *Search:* Sep. 2012\                                                        Range: 380--2554                                                                                               Mainland China studies                                                                                                                                                                                                                                                                                                                                                                                                        
  *\# incl. studies* 17\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Vehling [2012](#brb3497-bib-0055){ref-type="ref"} -- previously described                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Lim [2011](#brb3497-bib-0030){ref-type="ref"}\                              Patients 21--65 on treatment for early‐stage breast cancer\                                                    Women who were undergoing/had undergone breast cancer treatment (ex. RCT studies: patients from the center randomly selected to receive various treatment types; non‐RCT studies: women undergoing various cancer treatments/surgeries, patients from oncology clinics; patients assessed at home)\            Symptom checklists                                                                                             20% to 58%\
  *Search:* 2010\                                                             Range: 48--332                                                                                                 Clinical and community settings                                                                                                                                                                                                                                                                                                                                                                                               Less anxiety if given treatment choice\
  *\# incl. studies* 10\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   More state/trait anxiety during chemo than radiotherapy\
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Greater trait anxiety in young women during chemo

  Arden‐Close [2008](#brb3497-bib-0004){ref-type="ref"}\                      Ovarian cancer patients\                                                                                       Unclear (included patients, cancer survivors)\                                                                                                                                                                                                                                                                 Standardized and nonstandardized assessment tools, symptom checklists                                          Prev: 47% at 3 months following treatment\
  *Search:* May 2007\                                                         Range: 9--246                                                                                                  Mostly US studies                                                                                                                                                                                                                                                                                                                                                                                                             Anxiety levels increased from treatment completion date to 3‐month follow‐up\
  *\# incl. studies* 18\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Young age groups disproportionately affected
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Mitchell [2013](#brb3497-bib-0036){ref-type="ref"}\                         Adult patients compared with spouses, IQR sample size: 145--270\                                               Cases: outpatient clinic, database/cancer registry, hospitals, general population;\                                                                                                                                                                                                                            Symptom checklists, structured questionnaire for DSM, prescription of psychotropic drugs, clinical diagnosis   Prev. long‐term cancer survivors vs. healthy controls: 17.9% (12.8--23.6), 13.9% (9.8--18.5);\
  *Search:* March 2013\                                                       Adult patients and healthy controls IQR:1328--25,245                                                           recruitment: random sample (population‐based), patients treated in a certain time period; prescription for psychotropic drugs; Controls: comparator matching by sociodemographics, convenience sample, matched partner pair\                                                                                                                                                                                                  anxiety higher in cancer patients regardless of methodological factors\
  *\# incl. studies* 43\                                                                                                                                                                     Clinical and community settings                                                                                                                                                                                                                                                                                                                                                                                               Long‐term cancer survivors vs. spouses: 28% (22.3--33.9), 40.1% (25.4--55.9); age/sex effect not rep.
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  *Respiratory disease*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

  Janssen [2008](#brb3497-bib-0027){ref-type="ref"} -- previously described                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Solano [2006](#brb3497-bib-0050){ref-type="ref"} -- previously described                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  Davydow [2008](#brb3497-bib-0012){ref-type="ref"}\                          Adult survivors in the United States and Germany\                                                              Sampling not mentioned -- assessed patients following ICU discharge\                                                                                                                                                                                                                                           Symptom checklists                                                                                             23--48%
  *Search:* April 2007\                                                       321 patients                                                                                                   US and German studies                                                                                                                                                                                                                                                                                                                                                                                                         
  *\# incl. studies* 10\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  *Diabetes*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Smith [2013](#brb3497-bib-0048){ref-type="ref"}\                            Adults ages 16 +  years\                                                                                       Sampling not mentioned/unclear\                                                                                                                                                                                                                                                                                Surveys, clinical interview(s), validated scale                                                                Prev (HADS‐A): 15--73% in diabetic patients and 19.9--43.1% in ref groups\
  *Search:* July 2012\                                                        Range: 635--217,379                                                                                            Mostly North American and European studies                                                                                                                                                                                                                                                                                                                                                                                    Prev of anxiety disorders (clinical interviews):\
  *\# incl. studies* 12\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   1.4--15.6% in diabetic patients; 1.6--8.8% in ref
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Grigsby [2002](#brb3497-bib-0023){ref-type="ref"}\                          Adults ages 18 + \                                                                                             Most studies based on primary care/clinical samples                                                                                                                                                                                                                                                            Structured or semi‐structured diagnostic interviews, self‐report measures                                      Current and lifetime prev (%) of anxiety in diabetes:\
  *Search:* 2001\                                                             Range: 20--634 (for diabetic subjects)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       GAD: 13.5, 20.5; panic: 1.2, 1.9\
  *\# incl. studies* 18\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   OCD: 1.3, 1.1; Agoraphobia: 4.6, 10.2\
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     SP: 21.6, 24.8; SAD: 7.3, 9.3\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Any phobia: 6.8, 10.4\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Any anxiety disorder: 14.0, 25.8\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Anxiety not otherwise specified: 26.5, 39.0\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Elevated symptoms: 39.6\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Higher prev of anxiety symptoms in women than in men: 55.3 vs. 32.9\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           No diff by diab. Type; GAD most prevalent\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Anxiety dis. & symp: 25.8% & 39.6%

  Clarke [2009](#brb3497-bib-0010){ref-type="ref"} -- previously described                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  **Other chronic physical diseases**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Dokras [2012](#brb3497-bib-0014){ref-type="ref"}\                           PCOS subjects and non‐PCOS controls\                                                                           Screened clinic populations, 1 study used telephone screening\                                                                                                                                                                                                                                                 Anxiety screening tool                                                                                         Anxiety prev: 1--37.5% in PCOS; 0--13 in controls\
  *Search:* April 2011\                                                       Range: 44--206                                                                                                 Mostly clinical settings\                                                                                                                                                                                                                                                                                                                                                                                                     Prev of generalized anxiety symptoms in PCOS and controls: 20.4% vs 3.9%\
  *\# incl. studies* 9\                                                                                                                                                                      Mostly Western studies                                                                                                                                                                                                                                                                                                                                                                                                        SAD and OCD more common in PCOS; age effects not rep.
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Smith [2014](#brb3497-bib-0049){ref-type="ref"}\                            Mostly adult, Medi‐terranean pop.\                                                                             Clinically representative participants\                                                                                                                                                                                                                                                                                                                                                                                       Anxiety prev: 5--68% in BJHS; 5--32% in non‐BJHS\
  *Search:* January 2013\                                                     30 BJHS people & 25 controls‐182 people BJHS & 1123 controls                                                   Recruited participants from school settings, university, primary care/community health care settings, hospital outpatient departments                                                                                                                                                                                                                                                                                         BJHS have more PD, agoraphobia and fear than non‐BJHS
  *\# incl. studies* 14\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Andersen [2014](#brb3497-bib-0003){ref-type="ref"}\                         Adults (mean age: 43--50) from Western countries with musculoskeletal pain \>= 3 months\                       Primary care clinics or hospital services; recruitment: general population, through ads.; mostly outpatients\                                                                                                                                                                                                  Symptom checklists and structured clinical interview                                                           Pooled one‐year and lifetime prevalence of:\
  *Search:* Sept. 2012\                                                       Range: 84--3928                                                                                                Western studies                                                                                                                                                                                                                                                                                                                                                                                                               Clinical and general anxiety levels: 0--20.9% (highest prev. with SCID)\
  *\# incl. studies* 24\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Highest anxiety prev. in fibromyalgia
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Dawson [2014](#brb3497-bib-0013){ref-type="ref"}\                           Adults with age‐related macular degeneration (AMD) age 18 + \                                                  Recruited from eye clinics, GP clinics\                                                                                                                                                                                                                                                                        Almost all symptom checklists, structured clinical interview                                                   Generally no link with anxiety found, but one study reported prev of 30.1% in AMD
  *Search:* Feb 2012\                                                         Range: 51--32,702                                                                                              Clinical/specialist setting\                                                                                                                                                                                                                                                                                                                                                                                                  
  *\# incl. studies* 16\                                                                                                                                                                     Western studies, many US                                                                                                                                                                                                                                                                                                                                                                                                      
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  **Other chronic physical diseases in end‐stage**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Mitchell [2011](#brb3497-bib-0035){ref-type="ref"}\                         4007 adults age 18 +  in palliative care; 10,071 adults 18 +  in palliative care and oncological settings      Patients from oncological, hematological, and palliative‐care settings\                                                                                                                                                                                                                                        Psychiatric interviews                                                                                         9.8% (6.8--13.2) in palliative‐care, and 10.3% (5.1--17.0) in oncological and hematological settings
  *Search:* Nov. 2010\                                                                                                                                                                       Mostly Western studies                                                                                                                                                                                                                                                                                                                                                                                                        
  *\# incl. studies* 94\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Janssen [2008](#brb3497-bib-0027){ref-type="ref"} -- previously described                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Murtagh [2007](#brb3497-bib-0040){ref-type="ref"}\                          Adult patients diagnosis of end‐stage renal disease\                                                           Clinical settings                                                                                                                                                                                                                                                                                              Standardized psychiatric interview, survey, validated screening tools                                          Anxiety prev: 38% (12--52)
  *Search:* April 2005\                                                       Range: 19--5256                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  *\# incl. studies* 60\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  *Meta‐analysis:* No                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Solano [2006](#brb3497-bib-0050){ref-type="ref"} -- previously described                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  **Trauma**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Mckechnie [2014](#brb3497-bib-0033){ref-type="ref"}\                        Traumatic limb amputees, age 18 + \                                                                            Military patients (including veterans from Vietnam, Iraq, Afghanistan)\                                                                                                                                                                                                                                        ICD or DSM diagnoses, symptom checklists                                                                       Anxiety ranged from 25.4--57% in this pop
  *Search:* June 2013\                                                        Range: NR                                                                                                      Mostly UK and US studies                                                                                                                                                                                                                                                                                                                                                                                                      
  *\# incl. studies* 13\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Chen [2010](#brb3497-bib-0009){ref-type="ref"}\                             Individuals with history of sexual abuse compared to those without\                                            Registries, school health or GP records; referral from the rape crisis center, conscripts, voters, general population, friends of victims (controls)\                                                                                                                                                          Mostly structured diagnostic interview                                                                         Lifetime anxiety in people with sex abuse: 2--82%\
  *Search:* Dec. 2008\                                                        Range: 34--1,574,100                                                                                           Clinical, community settings                                                                                                                                                                                                                                                                                                                                                                                                  Associations between sexual abuse and MD persisted regardless of sex of survivor and age at which abuse occurred
  *\# incl. studies* 37 studies\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Fazel [2005](#brb3497-bib-0017){ref-type="ref"}\                            Adult refugees from southeast Asia, former Yugoslavia, middle east, Central America; weighted mean age = 27\   Opportunistic sampling (ex. student enrolment lists, health‐screening programs)\                                                                                                                                                                                                                               Clinical interview, trained interviewers using validated diagnostic methods                                    4% (3--6) of refugees diagnosed with GAD
  *Search:* Dec. 2002\                                                        6743 adult refugees                                                                                            High‐income western countries; ¾ participants from southeast Asia\                                                                                                                                                                                                                                                                                                                                                            
  *\# incl. studies* 20\                                                                                                                                                                     Community settings                                                                                                                                                                                                                                                                                                                                                                                                            
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  **Vulnerable population subgroups**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  *Older people and their caregivers*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Bryant [2008](#brb3497-bib-0007){ref-type="ref"}\                           People 60 +  years in community or clinical settings\                                                          Community surveys, GP lists, geriatric hospital, general hospital, case register, clinic referrals, consecutive series; participants included institutionalized older adults, nursing home residents                                                                                                           Checklists, self‐report, clinical record review, clinical diagnoses                                            Anxiety in community: 1.2--14%; anxiety in clinical samples: 1--28%\
  *Search:* 2007\                                                             Range: 286--10,641                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Anxiety symptoms: 15--52.3% in community and 15--56% in clinical samples\
  *\# incl. studies* 49\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   PD: 1.4--25.6%; Agoraphobia: 0.4--20%\
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      SP: 5.9--13.1%; SAD: 0.0--18.7%\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           OCD: 0.6--1.8%; PD: 0.0--10.5%\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           GAD commonest & more women with anxiety

  Volkert [2013](#brb3497-bib-0056){ref-type="ref"}\                          Older people 50 +  years mainly from Germany, US, Sweden\                                                      Mostly random samples, representative samples, 1 study contacted all elderly of one town, sample stratification according to various criteria\                                                                                                                                                                 Diagnostic interviews, dimensional instruments                                                                 Current and lifetime\
  *Search date:* Dec. 2011\                                                   Range: 242--22,777                                                                                             Community settings                                                                                                                                                                                                                                                                                                                                                                                                            PD: 0.88% (0.76, 0.99), 2.63% (2.43, 2.84)\
  *\# incl. studies* 25\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Agoraphobia: 0.53% (0.39, 0.66), 1.00% (0.54, 1.45); SP: 4.52% (4.15, 4.89), 6.66% (6.17, 7.15)\
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     SAD: 1.31% (1.18, 1.44), 5.07% (4.82, 5.32)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           GAD: 2.30% (2.03, 2.57), 6.36% (5.57, 7.14)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           OCD: 0.90% (0.63, 1.17), 0.97 (0.55, 1.38)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Lower SP prev in old

  Monastero [2009](#brb3497-bib-0039){ref-type="ref"}\                        Mean age at baseline ranged from 65--80 years\                                                                 Hospital‐based samples with MCI, population‐based samples with MCI, clinical trial of MCI subjects\                                                                                                                                                                                                            Behavioral instruments including diagnostic interviews (clinical interview, trained interviewer)               Prev: 11--74%\
  *Search:* Aug. 2008\                                                        Range: 44--2879                                                                                                Clinical and community settings                                                                                                                                                                                                                                                                                                                                                                                               Anxiety is common in Alzheimer\'s disease
  *\# incl. studies* 27\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Yates [2013](#brb3497-bib-0062){ref-type="ref"}\                            Clinical samples with MCI or community samples of older people\                                                People self‐referred or referred by GP to memory clinics; people recruited from general population                                                                                                                                                                                                             Anxiety symptom scales                                                                                         Prev. of anxiety: 11--75% in elderly with MCI\
  *Search:* Nov. 2012\                                                        Range: 18--6892                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Women and younger caregivers higher anxiety
  *\# incl. studies* 18\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Cooper [2007](#brb3497-bib-0011){ref-type="ref"}\                           Caregivers of people with dementia\                                                                            Case‐note review to identify caregivers of old people referred to psychiatry service; cohort studies\                                                                                                                                                                                                          Diagnostic interview schedules, symptom scale                                                                  3.7--76.5%\
  *Search:*2005\                                                              Range: 34--979                                                                                                 UK and US studies                                                                                                                                                                                                                                                                                                                                                                                                             Prev depended on study time period, sample, anxiety caseness definition
  *\# incl. studies* 33\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  *Pregnant women*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         

  Russell [2013](#brb3497-bib-0043){ref-type="ref"}\                          Pregnant and postpartum women (up to 12 months)\                                                               Community and outpatient referrals\                                                                                                                                                                                                                                                                            Structured diagnostic interviews                                                                               Overall prev: 1.08% (0.80, 1.46) in general pop of women, 2.07% (1.26, 3.37) during pregnancy, 2.43% (1.46, 4.00) during postpartum
  *Search:* August 2012\                                                      Range: 27--3929                                                                                                Controls: general population samples\                                                                                                                                                                                                                                                                                                                                                                                         
  *\# incl. studies* 17\                                                                                                                                                                     All continents included                                                                                                                                                                                                                                                                                                                                                                                                       
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Molyneaux [2014](#brb3497-bib-0038){ref-type="ref"}\                        Overweight or obese women at start of pregnancy vs normal weight control women\                                Medical records; women seeking prenatal care; primary care or hospital centre sample; all women living in Avon expected to deliver in a certain time period; Recruitment from prenatal exercise classes, obstetrician and gynaecologist waiting rooms (through newsletter), women with low‐income insurance\   Diagnostic and screening measures; did not include measures of state anxiety                                   Low‐income Brazilian women: anxiety prev 35% obese, 35.7% overweight, 31% normal weight\
  *Search:* Jan 2013\                                                         Total 540,373 women                                                                                            Clinical and community\                                                                                                                                                                                                                                                                                                                                                                                                       Postpartum anxiety prev: symptoms across studies ranged from 4.7% in obese (4% in overweight, 4.2% in normal weight) to 33.3% (13.3% in overweight, 16.4% normal weight)
  *\# incl. studies* 62\                                                                                                                                                                     Mostly Western studies (esp. UK and US)                                                                                                                                                                                                                                                                                                                                                                                       
  *Meta‐analysis:* insufficient studies for meta‐a for anxiety                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Sawyer [2010](#brb3497-bib-0044){ref-type="ref"}\                           Ethiopian and Nigerian women\                                                                                  Antenatal and postnatal health clinics, community\                                                                                                                                                                                                                                                             Most used structured clinical interviews, many used self‐administered measures, some used both                 Pre‐ and postnatal anxiety prevalence: 14.8% (12.3--17.4) and 14.0% (12.9--15.2)\
  *Search:* January 2009\                                                     Range: 101--632 (anxiety studies)                                                                              All studies from Africa, most from Nigeria                                                                                                                                                                                                                                                                                                                                                                                    Younger women more anxious
  *\# incl. studies* 35\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  *LGB and self‐harm patients*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  King [2008](#brb3497-bib-0029){ref-type="ref"}\                             Anxiety in LGB and\                                                                                            Random sampling, multi‐stage sampling, snowball sampling, some primary studies did not specify method\                                                                                                                                                                                                         Standardized scales                                                                                            Anxiety prev: 3--20% and 3--39% in men and women\
  *Search:* 2005\                                                             heterosexual groups\                                                                                           Community settings                                                                                                                                                                                                                                                                                                                                                                                                            Stigma and discrimination contributors
  *\# incl. studies* 25\                                                      Range: 79--194 (for anxiety studies)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Hawton [2013](#brb3497-bib-0025){ref-type="ref"}\                           All age patients presented to hospitals following self‐harm (self‐poisoning, self‐injury, suicide attempt)\    Consecutive admissions to different departments, recruitment on specific days, consecutive referrals to suicide unit, random sample\                                                                                                                                                                           Research diagnostic criteria and clinical diagnoses converted to DSM‐IV                                        Prev of anxiety disorders: 34.6% (21.9--48.6)\
  *Search:* Nov. 2011\                                                        Range: 22--1158                                                                                                Clinical samples\                                                                                                                                                                                                                                                                                                                                                                                                             Anxiety prev in women and men: 42% & 38%\
  *\# incl. studies* 50\                                                                                                                                                                     All studies of non‐Western countries from Asia, most Western studies from UK                                                                                                                                                                                                                                                                                                                                                  Small sex‐based diff.; prev high in young and old
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

SP, specific or simple phobia; PD, panic disorder; GAD, generalized anxiety disorder; SAD, social anxiety disorder; OCD, obsessive compulsive disorder; anx, anxiety; NR, not reported.

John Wiley & Sons, Ltd

 {#brb3497-sec-0038}

###### 

Directions for future research and reported limitations

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Review details                                                              Directions for future research                                                                                                                                                                 Reported limitations                                                                                                                                                                                                         QA[a](#brb3497-note-0003){ref-type="fn"}
  --------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------
  **Global distribution of anxiety disorders**                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Somers [2006](#brb3497-bib-0051){ref-type="ref"}\                           Incidence and onset studies needed\                                                                                                                                                            *Original studies*\                                                                                                                                                                                                          5
  *Search:* 2004\                                                             Research on anxiety risk & protective factors, and social variables as mediators\                                                                                                              Heterogeneity: diagnosis criteria and instruments used (ex. lower estimates with use of DIS and DSM‐III than CIDI and DSM‐III‐R)\                                                                                            
  *\# incl. studies* 39\                                                      Prev of anxiety in special groups (e.g., medical patients, residents of nursing homes)\                                                                                                        *Review*\                                                                                                                                                                                                                    
  *Meta‐analysis:* yes                                                        Clarify epidemiology of anxiety to help with deployment of treatment                                                                                                                           Heterogeneity: diff countries, response rate, sample size                                                                                                                                                                    

  Baxter [2013](#brb3497-bib-0005){ref-type="ref"}\                           Further research on:\                                                                                                                                                                          *Original studies*\                                                                                                                                                                                                          10
  *Search:* 2009\                                                             Impact of conflict on mental health\                                                                                                                                                           Limited measurement equivalence across cultures -- results should be interpreted with caution\                                                                                                                               
  *\# incl. studies* 87\                                                      Aspects of wealth related to anxiety\                                                                                                                                                          Rural study results -- should be interpreted with caution\                                                                                                                                                                   
  *Meta‐analysis:* yes                                                        Cultural aspects (ex. psycho‐stressors) related to anxiety\                                                                                                                                    Study design differences\                                                                                                                                                                                                    
                                                                              Further studies using consistent anxiety definition and methodologies in 1) developing and emerging countries; 2) populations exposed to conflict\                                             *Review*\                                                                                                                                                                                                                    
                                                                              Interactions of factors associated with prevalence of anxiety                                                                                                                                  NR                                                                                                                                                                                                                           

  Mirza [2004](#brb3497-bib-0034){ref-type="ref"}\                            Robust evidence (ex. conduct national, mental health epidemiology surveys) to develop mental health policy with strategic implementation plan for Pakistan\                                    *Original studies*\                                                                                                                                                                                                          5
  *Search:* March 2002\                                                       More outcome studies, prevention and treatment trials needed                                                                                                                                   Most studies from Punjab and Sind\                                                                                                                                                                                           
  *\# incl. studies:* 20\                                                                                                                                                                                                                                                    Heterogeneity in study design and instruments -- limited generalizability\                                                                                                                                                   
  *Meta‐analysis:* no                                                                                                                                                                                                                                                        *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Publication and selection bias\                                                                                                                                                                                              
                                                                                                                                                                                                                                                                             Small number of included studies                                                                                                                                                                                             

  Vehling [2012](#brb3497-bib-0055){ref-type="ref"}\                          Representative studies                                                                                                                                                                         *Original studies*\                                                                                                                                                                                                          7
  *Search: not rep.*\                                                                                                                                                                                                                                                        Estimate heterogeneity and study quality\                                                                                                                                                                                    
  *\# incl. studies* 89\                                                                                                                                                                                                                                                     Limited generalizability\                                                                                                                                                                                                    
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                       *Review*                                                                                                                                                                                                                     

  Baxter [2014](#brb3497-bib-0006){ref-type="ref"}\                                                                                                                                                                                                                          *Original studies*\                                                                                                                                                                                                          10
  *Search:* 2009\                                                                                                                                                                                                                                                            Limited or no data from Central Asia, Andean Latin America, Oceania, Central sub‐Saharan Africa, Central Europe, South‐east Asia\                                                                                            
  *\# incl. studies* 91\                                                                                                                                                                                                                                                     Possibly biased population samples (ex. conflict region studies may have oversampled those exposed to conflict)\                                                                                                             
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                       *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             NR                                                                                                                                                                                                                           

  Haller [2014](#brb3497-bib-0024){ref-type="ref"}\                           Clarify subthreshold GAD vs. nonpathological anxiety -- use impairment criterion for this\                                                                                                     *Original studies*\                                                                                                                                                                                                          7
  *Search:* 2006\                                                             Should treatment strategies used for threshold disorders be used for subthreshold cases?                                                                                                       Inadequate study response rates\                                                                                                                                                                                             
  *\# incl. studies:* 18\                                                                                                                                                                                                                                                    Heterogeneous definitions of subthreshold GAD\                                                                                                                                                                               
  *Meta‐analysis:* no                                                                                                                                                                                                                                                        *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Some studies missed\                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                             Difficult to define search terms for subthreshold GAD\                                                                                                                                                                       
                                                                                                                                                                                                                                                                             Insufficient studies for subpopulations\                                                                                                                                                                                     
                                                                                                                                                                                                                                                                             Different study quality                                                                                                                                                                                                      

  Steel [2014](#brb3497-bib-0052){ref-type="ref"}\                                                                                                                                                                                                                           *Original studies*\                                                                                                                                                                                                          5
  *Search:* Jan 2014\                                                                                                                                                                                                                                                        Some recall bias with 12‐month estimates\                                                                                                                                                                                    
  *\# incl. studies* 174\                                                                                                                                                                                                                                                    Different study age structures contributing to different prev\                                                                                                                                                               
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                       Higher prev with smaller sample sizes\                                                                                                                                                                                       
                                                                                                                                                                                                                                                                             Different estimates with the use of different instruments\                                                                                                                                                                   
                                                                                                                                                                                                                                                                             Adaptation of surveys to culture and context & measurement equivalence issues\                                                                                                                                               
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Some studies may have been missed\                                                                                                                                                                                           
                                                                                                                                                                                                                                                                             Untested search strategies\                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                             Assessment equivalence across cultures\                                                                                                                                                                                      
                                                                                                                                                                                                                                                                             Can only generalize findings to adults                                                                                                                                                                                       

  **Addiction**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Fatseas [2010](#brb3497-bib-0016){ref-type="ref"}\                          Effectiveness of treatment for phobias in opiate‐dependent patients                                                                                                                            *Original studies*\                                                                                                                                                                                                          6
  *Search:* Jan. 2009\                                                                                                                                                                                                                                                       Reliability and validity of diagnostic tools (ex. difficult to distinguish substance‐induced anxiety from independent disorders with pre‐DSM‐IV criteria)\                                                                   
  *\# incl. studies* 18\                                                                                                                                                                                                                                                     Heterogeneity in sample characteristics\                                                                                                                                                                                     
  *Meta‐analysis:* no                                                                                                                                                                                                                                                        Different time frames for prev of anxiety\                                                                                                                                                                                   
                                                                                                                                                                                                                                                                             *Review*                                                                                                                                                                                                                     

  Fischer [2012](#brb3497-bib-0018){ref-type="ref"}\                          Longitudinal studies to assess reasons for using NMPOU in individuals with mental health problems                                                                                              *Original studies*\                                                                                                                                                                                                          8
  *Search:* Dec. 2011\                                                                                                                                                                                                                                                       Heterogeneity: operationalization of anxiety and NMPOU\                                                                                                                                                                      
  *\# incl. studies* 9\                                                                                                                                                                                                                                                      Many screener or epidemiological instruments used (possible overestimation), instead of clinical diagnostic tools\                                                                                                           
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                       All North American studies -- limited generalizability\                                                                                                                                                                      
                                                                                                                                                                                                                                                                             Small number of studies\                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Between‐study heterogeneity                                                                                                                                                                                                  

  Goldner [2014](#brb3497-bib-0021){ref-type="ref"}\                          Relationship between NMPOU and mental illness\                                                                                                                                                 *Original studies*\                                                                                                                                                                                                          8
  *Search:* April 2012\                                                       Retrospective and prospective studies to examine development of mental health problems and NMPOU in those receiving POAs\                                                                      Cross‐sectional data, thus temporality issues between NMPOU and mental illness\                                                                                                                                              
  *\# incl. studies* 11\                                                      Use standardized and comparable diagnostic instruments\                                                                                                                                        Diff instruments used\                                                                                                                                                                                                       
  *Meta‐analysis:* yes                                                        Link between chronic pain and mental illness\                                                                                                                                                  *Review*\                                                                                                                                                                                                                    
                                                                              Alternative treatments for and outcomes of patients with both mental health problems and NMPOU                                                                                                 Publication bias\                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                             High between‐study differences\                                                                                                                                                                                              
                                                                                                                                                                                                                                                                             Heterogeneity: defining and measuring NMPOU psychiatric problems                                                                                                                                                             

  Lorains [2011](#brb3497-bib-0031){ref-type="ref"}\                          Health care workers should:\                                                                                                                                                                   *Original studies*\                                                                                                                                                                                                          5
  *Search:* Sept. 2010\                                                       Assess for comorbidities\                                                                                                                                                                      Lifetime estimates may be confounded by age\                                                                                                                                                                                 
  *\# incl. studies* 11\                                                      Determine whether anxiety developed before gambling problem and should be treated first                                                                                                        Diff tools (ex. SOGS -- satisfactory psychometrics in populations surveys; discordance between NODS and DSM‐IV)\                                                                                                             
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                       Most general population prevalence surveys conducted in the United States and Canada, small sample sizes\                                                                                                                    
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             NR                                                                                                                                                                                                                           

  Ho [2014](#brb3497-bib-0026){ref-type="ref"}\                               Genetic transmission of IA\                                                                                                                                                                    *Original*\                                                                                                                                                                                                                  8
  *Search:* 2012\                                                             Patients with IA should be screened for anxiety and vice versa & integrated treatment recommended\                                                                                             Heterogeneity: age of sample, different psychiatric questionnaires, mostly cross‐sectional studies, uncontrolled confounding (ex. environmental stress, parenting)\                                                          
  *\# incl. studies* 8\                                                       Further studies on moderators; other ethnic groups in Europe and North America; older adults\                                                                                                  Young patients mainly from Asian countries\                                                                                                                                                                                  
  *Meta‐analysis:* yes                                                        Studies on interactions between IA and anxiety (etiology, illness trajectory, treatment outcomes)\                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                              Consensus on definition of IA\                                                                                                                                                                 Small number of studies\                                                                                                                                                                                                     
                                                                              Prospective studies\                                                                                                                                                                           Unable to assess how estimates differ with use of self‐reported questionnaires vs. structured interviews                                                                                                                     
                                                                              Link between anxiety and IA‐specific behaviors (ex. use of social media)                                                                                                                                                                                                                                                                                                                                                    

  **Other mental and neurological disorders**                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Fajutrao [2009](#brb3497-bib-0015){ref-type="ref"}\                         Bipolar disorder in Europe                                                                                                                                                                     *Original studies*\                                                                                                                                                                                                          5
  *Search:* past 10 years\                                                                                                                                                                                                                                                   Anxiety assessment and reporting methods diff\                                                                                                                                                                               
  *\# incl. studies* 26\                                                                                                                                                                                                                                                     Retrospective and nonrepresentative samples\                                                                                                                                                                                 
  *Meta‐analysis:* no                                                                                                                                                                                                                                                        *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Focus on electronic databases; language selection criteria                                                                                                                                                                   

  Amerio [2014](#brb3497-bib-0002){ref-type="ref"}\                           Assess history of mood disorders in OCD patients\                                                                                                                                              *Original studies*\                                                                                                                                                                                                          5
  *Search:* Mar 2013\                                                         Treatment research (ex. use of mood stabilizers)\                                                                                                                                              Differences in evaluation, diagnosis, reporting\                                                                                                                                                                             
  *\# incl. studies:* 64\                                                     Studies on hereditary and biological markers, diagnostic validity of BD‐OCD comorbidity and its treatments                                                                                     Mostly observational, retrospective studies, lack of control group, small sample size, sampling bias\                                                                                                                        
  *Meta‐analysis:* no                                                                                                                                                                                                                                                        *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             NR                                                                                                                                                                                                                           

  Swets [2014](#brb3497-bib-0053){ref-type="ref"}\                            Use random sampling\                                                                                                                                                                           *Original studies*\                                                                                                                                                                                                          5
  *Search:* Dec 2009\                                                         Training needed to assess OCS\                                                                                                                                                                 Different instruments and criteria used (ex. lower estimates with DSM‐III‐R than later versions; lower prev with DIGS)\                                                                                                      
  *\# incl. studies* 43\                                                      Diagnostic standardization needed, careful patient selection\                                                                                                                                  Sampling variability (different patient characteristics)\                                                                                                                                                                    
  *Meta‐analysis:* yes                                                        Detailed assessment of OCD; use SCID OCD def. followed by Y‐BOCS administration\                                                                                                               Possible sampling bias, help‐seeking/patients selection can influence prev rates\                                                                                                                                            
                                                                              Assess OCS in patients with psychosis\                                                                                                                                                         Limited data on: sub‐Sahara African countries, gender, ethnicity, use of meds (ex. antipsychotics)\                                                                                                                          
                                                                              Shift from descriptive to treatment studies                                                                                                                                                    *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             NR                                                                                                                                                                                                                           

  Marrie [2015](#brb3497-bib-0032){ref-type="ref"}\                           Be consistent: compare psychometric properties of instruments and use same instrument to assess anxiety\                                                                                       *Original*\                                                                                                                                                                                                                  5
  *Search:* Nov. 2013\                                                        Standardize estimates to common (world) population                                                                                                                                             Differences in study design: different data sources, populations, definitions of psychiatric disorders\                                                                                                                      
  *\# incl. studies* 118\                                                                                                                                                                                                                                                    Little info on age‐, sex‐, or ethnicity‐specific estimates\                                                                                                                                                                  
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                       *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             NR                                                                                                                                                                                                                           

  **Chronic physical diseases**                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  *Cardiovascular disease*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Janssen [2008](#brb3497-bib-0027){ref-type="ref"}\                          Prospective research that considers view of patients, their families, their physician for symptom management                                                                                   *Original studies*\                                                                                                                                                                                                          5
  *Search:* 2007\                                                                                                                                                                                                                                                            Different rates of symptom reporting with different proxies and depending on timing of interview\                                                                                                                            
  *\# incl. studies* 39\                                                                                                                                                                                                                                                     Differences in: methods of reporting; definition of end‐of‐life (ex. different estimates in last week vs. last year of life); patient characteristics; definition and measurement of symptoms\                               
  *Meta‐analysis:* no                                                                                                                                                                                                                                                        *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             NR                                                                                                                                                                                                                           

  Solano [2006](#brb3497-bib-0050){ref-type="ref"}\                                                                                                                                                                                                                          *Original studies*\                                                                                                                                                                                                          5
  *Search:* June 2004\                                                                                                                                                                                                                                                       Heterogeneity in definition of symptoms (different criteria), methods to detect cases of symptoms (different questionnaires and screening methods used), study design, sampling, study setting, methods of data collection   
  *\# incl. studies* 64\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  *Meta‐analysis:* no                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Tully [2013](#brb3497-bib-0054){ref-type="ref"}\                            Further GAD research in CHD\                                                                                                                                                                   *Original studies*\                                                                                                                                                                                                          6
  *Search:* May 2011\                                                         Specific anxiety disorders rather than trait/state anxiety\                                                                                                                                    Heterogeneity: diagnostic criteria for GAD, gender ratio, patient age\                                                                                                                                                       
  *\# incl. studies* 12\                                                      "Any anxiety" not clinically informative in cardiac settings                                                                                                                                   *Review*\                                                                                                                                                                                                                    
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                       Low rate of publications on GAD                                                                                                                                                                                              

  Clarke [2009](#brb3497-bib-0010){ref-type="ref"}\                           Effectiveness of interventions\                                                                                                                                                                *Original studies*\                                                                                                                                                                                                          7
  *Search:* May 2003\                                                         Large prospective studies\                                                                                                                                                                     Different rating tools & diagnostic criteria; low power\                                                                                                                                                                     
  *\# incl. studies* 159\                                                     Anxiety assessed in parallel with chronic conditions                                                                                                                                           *Review*\                                                                                                                                                                                                                    
  *Meta‐analysis:* no                                                                                                                                                                                                                                                        Heterogeneity                                                                                                                                                                                                                

  Webster [2012](#brb3497-bib-0058){ref-type="ref"}\                          Theory‐driven research to examine link between patients' perceptions (ex. chest pain) and mental health\                                                                                       *Original studies*\                                                                                                                                                                                                          5
  *Search:* Nov. 2010\                                                        Does providing explanations for patients' chest pain reduce their anxiety?\                                                                                                                    Different caseness cut‐offs\                                                                                                                                                                                                 
  *\# incl. studies* 12\                                                      Longitudinal design to assess mental health trajectory in NCCP\                                                                                                                                Risk factor research used cross‐sectional designs\                                                                                                                                                                           
  *Meta‐analysis:* no                                                         Use reliable and valid measures for mental disorders with recommended cut‐offs                                                                                                                 Few studies on correlates of poor mental health in NCCP\                                                                                                                                                                     
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Possible publication bias\                                                                                                                                                                                                   
                                                                                                                                                                                                                                                                             Large heterogeneity in study settings                                                                                                                                                                                        

  Campbell Burton [2013](#brb3497-bib-0008){ref-type="ref"}\                  Mood assessment tools appropriate for stroke patients\                                                                                                                                         *Original studies*\                                                                                                                                                                                                          10
  *Search:* March 2011\                                                       Guidance on best time to screen for anxiety\                                                                                                                                                   Different cut‐off scores used\                                                                                                                                                                                               
  *\# incl. studies* 44\                                                      What is the impact of anxiety and its economic burden in the context of stroke?                                                                                                                Most studies cross‐sectional, so difficult to determine whether pre‐stroke anxiety is linked to post‐stroke anxiety\                                                                                                         
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                       Few studies differentiated btw. "first‐ever" and "current anxiety"\                                                                                                                                                          
                                                                                                                                                                                                                                                                             Some scales were not validated in stroke populations\                                                                                                                                                                        
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Potential publication bias & heterogeneity\                                                                                                                                                                                  
                                                                                                                                                                                                                                                                             Some studies not included in review                                                                                                                                                                                          

  *Cancer*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  Clarke [2009](#brb3497-bib-0010){ref-type="ref"} -- previously described                                                                                                                                                                                                                                                                                                                                                                                                                                

  Solano [2006](#brb3497-bib-0050){ref-type="ref"} -- previously described                                                                                                                                                                                                                                                                                                                                                                                                                                

  Yang [2013](#brb3497-bib-0062){ref-type="ref"}\                             Use control groups with diseases other than cancer                                                                                                                                             *Original studies*\                                                                                                                                                                                                          9
  *Search:* Sep. 2012\                                                                                                                                                                                                                                                       Anxiety assessed using different instruments\                                                                                                                                                                                
  *\# incl. studies* 17\                                                                                                                                                                                                                                                     Studies were cross‐sectional so cannot determine temporality between anxiety and cancer development\                                                                                                                         
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                       *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Few studies & lacking international literature\                                                                                                                                                                              
                                                                                                                                                                                                                                                                             Potential publication bias                                                                                                                                                                                                   

  Vehling [2012](#brb3497-bib-0055){ref-type="ref"} -- previously described                                                                                                                                                                                                                                                                                                                                                                                                                               

  Lim [2011](#brb3497-bib-0030){ref-type="ref"}\                              Studies in different settings assessing effect of cancer treatment on anxiety\                                                                                                                 *Original studies*\                                                                                                                                                                                                          6
  *Search:* 2010\                                                             Interventions for anxiety in women with breast cancer\                                                                                                                                         Small sample sizes\                                                                                                                                                                                                          
  *\# incl. studies* 10\                                                      Ways to decrease state anxiety and help women cope with chemotherapy, despite their level of trait anxiety                                                                                     *Review*\                                                                                                                                                                                                                    
  *Meta‐analysis:* no                                                                                                                                                                                                                                                        Difference in treatment, tools & timing of measurement                                                                                                                                                                       

  Arden‐Close [2008](#brb3497-bib-0004){ref-type="ref"}\                      Longitudinal studies and RCTs needed to clarify directionality between immunity and mental illness\                                                                                            *Original studies*\                                                                                                                                                                                                          6
  *Search:* May 2007\                                                         Prospective research needed to test trajectories of change in mental illness following cancer diagnosis and treatment\                                                                         Certain correlates of mental illness tested in too few studies\                                                                                                                                                              
  *\# incl. studies* 18\                                                      Interventions targeting distress (ex. coping)\                                                                                                                                                 Lack of validation of assessment tools\                                                                                                                                                                                      
  *Meta‐analysis:* no                                                         Attention to sample size and validation of questionnaires\                                                                                                                                     Small sample sizes\                                                                                                                                                                                                          
                                                                              Theory‐driven research needed\                                                                                                                                                                 Residual confounding\                                                                                                                                                                                                        
                                                                              Authors should state limitations/directions for future research                                                                                                                                Limited generalisability (US)\                                                                                                                                                                                               
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Published studies                                                                                                                                                                                                            

  Mitchell [2013](#brb3497-bib-0036){ref-type="ref"}\                         Link between health‐related quality of life and anxiety\                                                                                                                                       *Original studies*\                                                                                                                                                                                                          11
  *Search:* March 2013\                                                       Studies on anxiety in palliative settings or in patients with advanced cancer\                                                                                                                 Differences in: quality of matching with healthy controls, study quality, study design, case ascertainment\                                                                                                                  
  *\# incl. studies* 43 *Meta‐analysis:* yes                                  More reliable estimates by use of interview methods                                                                                                                                            Possible uncontrolled factors\                                                                                                                                                                                               
                                                                                                                                                                                                                                                                             Heterogeneity in healthy controls (review authors had limited info on recruitment of healthy controls in studies)\                                                                                                           
                                                                                                                                                                                                                                                                             *Review* -- NR                                                                                                                                                                                                               

  *Respiratory disease*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Janssen [2008](#brb3497-bib-0027){ref-type="ref"} -- previously described                                                                                                                                                                                                                                                                                                                                                                                                                               

  Solano [2006](#brb3497-bib-0050){ref-type="ref"} -- previously described                                                                                                                                                                                                                                                                                                                                                                                                                                

  Davydow [2008](#brb3497-bib-0012){ref-type="ref"}\                          Risk factors for psychopathology\                                                                                                                                                              *Original studies*\                                                                                                                                                                                                          5
  *Search:* April 2007\                                                       More rigorous assessment of psychopathology\                                                                                                                                                   Mostly psychiatric questionnaires used with diff. sensitivities, ex. screening instruments or measures of symptom severity (not necessarily validated for ARDS survivors)\                                                   
  *\# incl. studies* 10\                                                      Anxiety in ICU as risk factor for post‐ALI/ARDS psychopathology\                                                                                                                               Small sample sizes\                                                                                                                                                                                                          
  *Meta‐analysis:* no                                                         To what extent are risk factors for ALI/ARDS related to development of mental illness in those without ALI/ARDS                                                                                *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Small number of studies                                                                                                                                                                                                      

  *Diabetes*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Smith [2013](#brb3497-bib-0048){ref-type="ref"}\                            Individual anxiety disorders associated with diabetes\                                                                                                                                         *Original studies*\                                                                                                                                                                                                          10
  *Search:* July 2012\                                                        Relevant confounders should be included\                                                                                                                                                       Different time frames resulting in different likelihood of capturing symptoms\                                                                                                                                               
  *\# incl. studies* 12\                                                      Studies on diabetes and anxiety using accurate measurements\                                                                                                                                   Measurement differences\                                                                                                                                                                                                     
  *Meta‐analysis:* yes                                                        Prospective studies to clarify directionality between anxiety and diabetes                                                                                                                     Cross‐sectional data\                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                             Temporality between diabetes and anxiety\                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Publication bias, language biases                                                                                                                                                                                            

  Grigsby [2002](#brb3497-bib-0023){ref-type="ref"}\                          Longitudinal studies to identify behavioral and physiological mechanisms related to anxiety in diabetes\                                                                                       *Original studies*\                                                                                                                                                                                                          6
  *Search:* 2001\                                                             More community‐based studies to estimate anxiety prev in diabetes\                                                                                                                             Small sample sizes\                                                                                                                                                                                                          
  *\# incl. studies* 18\                                                      Assess potential moderators\                                                                                                                                                                   Lacking data on race/ethnicity influence on anxiety prev\                                                                                                                                                                    
  *Meta‐analysis:* yes                                                        Studies on causal mechanisms                                                                                                                                                                   Differences in scales used to measure anxiety and in aggregation/reporting of results (ex. assessment of 1 anxiety disorder vs. aggregate of several anxiety disorders)\                                                     
                                                                                                                                                                                                                                                                             Lack of data on prev of anxiety by diabetes type\                                                                                                                                                                            
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Small number of studies\                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                             Few studies included nondiabetic comparison group                                                                                                                                                                            

  Clarke [2009](#brb3497-bib-0010){ref-type="ref"} -- previously described                                                                                                                                                                                                                                                                                                                                                                                                                                

  **Other chronic physical diseases**                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Dokras [2012](#brb3497-bib-0014){ref-type="ref"}\                           Effect of clinical or biochemical factors in relation to hyperandrogenism and anxiety in PCOS\                                                                                                 *Original studies*\                                                                                                                                                                                                          5
  *Search:* April 2011\                                                       Link between PCOS‐specific characteristics and anxiety\                                                                                                                                        Few studies on prev on anxiety in PCOS using validated anxiety screening tools\                                                                                                                                              
  *\# incl. studies* 9\                                                       Larger sample sizes\                                                                                                                                                                           Mostly cross‐sectional studies\                                                                                                                                                                                              
  *Meta‐analysis:* yes                                                        Longitudinal studies for insight into etiology and trajectory of anxiety in PCOS                                                                                                               *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Small sample sizes, possible publication bias                                                                                                                                                                                

  Smith [2014](#brb3497-bib-0049){ref-type="ref"}\                            Degree of BJHS related to mental illness\                                                                                                                                                      *Original studies*\                                                                                                                                                                                                          7
  *Search:* January 2013\                                                     Biological link between BJHS and anxiety (ex. abnormal reactive autonomic nervous system)\                                                                                                     Limited generalizability (mainly Mediterranean adult populations), mostly cross‐sectional designs\                                                                                                                           
  *\# incl. studies* 14\                                                      Influence of nonpharmacologic treatment on alleviating anxiety in those with BJHS\                                                                                                             Possible cross‐cultural differences in expression of anxiety\                                                                                                                                                                
  *Meta‐analysis:* yes                                                        Anxiety in BJHS in other cultures                                                                                                                                                              *Review*                                                                                                                                                                                                                     

  Andersen [2014](#brb3497-bib-0003){ref-type="ref"}\                                                                                                                                                                                                                        *Original studies*\                                                                                                                                                                                                          6
  *Search:* Sept. 2012\                                                                                                                                                                                                                                                      Different recruitment methods, study inclusion criteria\                                                                                                                                                                     
  *\# incl. studies* 24\                                                                                                                                                                                                                                                     Most study patients were women, thus, possible overestimation of significance of results\                                                                                                                                    
  *Meta‐analysis:* no                                                                                                                                                                                                                                                        Different measurement methods: questionnaires, clinical evaluations, structured interviews (some methods not validated for pain patients)\                                                                                   
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Search strategy                                                                                                                                                                                                              

  Dawson [2014](#brb3497-bib-0013){ref-type="ref"}\                           Does anxiety come before onset of AMD?\                                                                                                                                                        *Original studies*\                                                                                                                                                                                                          5
  *Search:* Feb 2012\                                                         Link between length of time since AMD diagnosis and AMD treatments in relation to patient\'s mental health\                                                                                    Is anxiety different in different forms of AMD?\                                                                                                                                                                             
  *\# incl. studies* 16\                                                      Include control group to compare prev of anxiety between AMD and non‐AMD populations\                                                                                                          Different definition and measurement of anxiety\                                                                                                                                                                             
  *Meta‐analysis:* no                                                         Use tools with clear cut‐off for clinical anxiety                                                                                                                                              Comparison group may not be representative\                                                                                                                                                                                  
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Small number of studies                                                                                                                                                                                                      

  **Other chronic physical diseases in end‐stage**                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Mitchell [2011](#brb3497-bib-0035){ref-type="ref"}\                                                                                                                                                                                                                        *Original studies*\                                                                                                                                                                                                          8
  *Search:* Nov. 2010\                                                                                                                                                                                                                                                       No consensus about optimum psychiatric diagnostic approach in cancer settings\                                                                                                                                               
  *\# incl. studies* 94\                                                                                                                                                                                                                                                     Studies of variable quality, mostly cross‐sectional designs, some used convenience sampling, different anxiety measurement methods\                                                                                          
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                       Could not determine correlates of anxiety\                                                                                                                                                                                   
                                                                                                                                                                                                                                                                             Few studies with defined period of prevalence\                                                                                                                                                                               
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Possible publication bias                                                                                                                                                                                                    

  Janssen [2008](#brb3497-bib-0027){ref-type="ref"} -- previously described                                                                                                                                                                                                                                                                                                                                                                                                                               

  Murtagh [2007](#brb3497-bib-0040){ref-type="ref"}\                          Studies on incidence and prevalence of symptoms in ESRD, their causes, and interventions\                                                                                                      *Original studies*\                                                                                                                                                                                                          6
  *Search:* April 2005\                                                       Population‐based, longitudinal studies\                                                                                                                                                        Heterogeneity: symptom definition, who defines a symptom (reporting), different periods over which prevalence is measured, different tools used\                                                                             
  *\# incl. studies* 60\                                                      More information on generalizability of available studies\                                                                                                                                     No population‐based studies\                                                                                                                                                                                                 
  *Meta‐analysis:* No                                                         How do symptoms vary between those managed without dialysis and those withdrawing from dialysis?\                                                                                              *Review*\                                                                                                                                                                                                                    
                                                                              Symptom burden in ESRD\                                                                                                                                                                        Search strategy                                                                                                                                                                                                              
                                                                              Symptoms experienced at end of life\                                                                                                                                                                                                                                                                                                                                                                                        
                                                                              Identify what is common and different between those dying from ESRD and other palliative populations                                                                                                                                                                                                                                                                                                                        

  Solano [2006](#brb3497-bib-0050){ref-type="ref"} -- previously described                                                                                                                                                                                                                                                                                                                                                                                                                                

  **Trauma**                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Mckechnie [2014](#brb3497-bib-0033){ref-type="ref"}\                        Prospective studies assessing long‐term levels of anxiety in post‐traumatic amputees, and whether rehab programmes are successful and mental health issues continue after the programme ends   *Original*\                                                                                                                                                                                                                  8
  *Search:* June 2013\                                                                                                                                                                                                                                                       No info on how prev changes with time since amputation (anxiety assessed at fixed time point)\                                                                                                                               
  *\# incl. studies* 13\                                                                                                                                                                                                                                                     Different scoring systems in different populations at various follow‐up times\                                                                                                                                               
  *Meta‐analysis:* no                                                                                                                                                                                                                                                        Selected specialist samples not representative of all traumatic amputees\                                                                                                                                                    
                                                                                                                                                                                                                                                                             Sampling -- possible selection bias\                                                                                                                                                                                         
                                                                                                                                                                                                                                                                             Attrition during follow‐up\                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Some studies may have been missed                                                                                                                                                                                            

  Chen [2010](#brb3497-bib-0009){ref-type="ref"}\                             Interplay between stressful life events, vulnerability genes, and development of psychiatric disorders (gene‐environment interactions)                                                         *Original studies*\                                                                                                                                                                                                          8
  *Search:* Dec. 2008\                                                                                                                                                                                                                                                       Self‐report (recall bias), abuse underreport\                                                                                                                                                                                
  *\# incl. studies* 37 studies\                                                                                                                                                                                                                                             Anxiety affected by unmeasured forms of abuse?\                                                                                                                                                                              
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                       *Review*                                                                                                                                                                                                                     

  Fazel [2005](#brb3497-bib-0017){ref-type="ref"}\                                                                                                                                                                                                                           *Original studies*\                                                                                                                                                                                                          5
  *Search:* Dec. 2002\                                                                                                                                                                                                                                                       Measurement equivalence issues: differences in sampling methods, diagnostic instruments\                                                                                                                                     
  *\# incl. studies* 20\                                                                                                                                                                                                                                                     Insufficient data on refugees in developing countries, asylum seekers, people internally displaced in their own countries\                                                                                                   
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                       Updated info on recently displaced refugees\                                                                                                                                                                                 
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             NR                                                                                                                                                                                                                           

  **Vulnerable population subgroups**                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  *Older people and their caregivers*                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Bryant [2008](#brb3497-bib-0007){ref-type="ref"}\                           Hypothesis‐driven research with late‐life anxiety as primary focus\                                                                                                                            *Original studies*\                                                                                                                                                                                                          5
  *Search:* 2007\                                                             Longitudinal designs\                                                                                                                                                                          Differences in definition and measurement of anxiety\                                                                                                                                                                        
  *\# incl. studies* 49\                                                      Studies on anxiety in old age\                                                                                                                                                                 Measurement equivalence issues in elderly -- is anxiety experienced differently in elderly? (case definition)\                                                                                                               
  *Meta‐analysis:* no                                                         Prevention and early treatment should target old people in poor health and who are at risk for anxiety                                                                                         Difficult to disentangle physical symptoms & anxiety in elderly\                                                                                                                                                             
                                                                                                                                                                                                                                                                             Possible selection bias\                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                             Older people may underreport anxiety\                                                                                                                                                                                        
                                                                                                                                                                                                                                                                             Mostly cross‐sectional studies\                                                                                                                                                                                              
                                                                                                                                                                                                                                                                             *Review*                                                                                                                                                                                                                     

  Volkert [2013](#brb3497-bib-0056){ref-type="ref"}\                          Studies on anxiety in elderly using improved methodology and accounting for changes in old age (adapted instruments)                                                                           Differences in instruments and diagnostic criteria\                                                                                                                                                                          8
  *Search date:* Dec. 2011\                                                                                                                                                                                                                                                  Difficult to disentangle anxiety from physical diseases, somatoform disorders, and depression in elderly\                                                                                                                    
  *\# incl. studies* 25\                                                                                                                                                                                                                                                     Instruments not designed for elderly -- what constitutes anxiety in elderly?\                                                                                                                                                
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                       Heterogeneity: studies of different geographic and cultural regions and using different case definitions and case identification methods\                                                                                    
                                                                                                                                                                                                                                                                             Difficult to recruit elderly for studies\                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Studies in English and German -- limited generalizability\                                                                                                                                                                   
                                                                                                                                                                                                                                                                             No missing data analysis                                                                                                                                                                                                     

  Monastero [2009](#brb3497-bib-0039){ref-type="ref"}\                        Health care worker to distinguish primary behavioral changes from cognitive impairment\                                                                                                        *Original studies*\                                                                                                                                                                                                          5
  *Search:* Aug. 2008\                                                        Large, cohort studies using standardized instruments to assess NPS as prognostic factors in MCI\                                                                                               Possible selection bias\                                                                                                                                                                                                     
  *\# incl. studies* 27\                                                      Optimum ways to assess NPS in those with MCI\                                                                                                                                                  Differences in age and sex distributions within studies\                                                                                                                                                                     
  *Meta‐analysis:* no                                                         Genetic and biological markers linking NPS to MCI and dementia                                                                                                                                 Differences in instruments used/methods of reporting symptoms\                                                                                                                                                               
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             NR                                                                                                                                                                                                                           

  Yates [2013](#brb3497-bib-0062){ref-type="ref"}\                            Anxiety and depression should both be considered\                                                                                                                                              *Original studies*\                                                                                                                                                                                                          5
  *Search:* Nov. 2012\                                                        Classification systems for MCI should consider anxiety\                                                                                                                                        Heterogeneity: sampling differences, small samples (may not be representative), different ways of assessing mood/NPS\                                                                                                        
  *\# incl. studies* 18\                                                      Clarify directionality between anxiety and MCI                                                                                                                                                 Lacking info on link between anxiety and MCI subtypes\                                                                                                                                                                       
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                       *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Possible publication bias, English articles                                                                                                                                                                                  

  Cooper [2007](#brb3497-bib-0011){ref-type="ref"}\                           Cohort studies\                                                                                                                                                                                *Original studies*\                                                                                                                                                                                                          5
  *Search:*2005\                                                              Research on coping in relation to anxiety (this could be intervention target)                                                                                                                  Lack of info on determinants of anxiety caseness in caregivers\                                                                                                                                                              
  *\# incl. studies* 33\                                                                                                                                                                                                                                                     *Review*\                                                                                                                                                                                                                    
  *Meta‐analysis:* no                                                                                                                                                                                                                                                        NR                                                                                                                                                                                                                           

  *Pregnant women*                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Russell [2013](#brb3497-bib-0043){ref-type="ref"}\                          Prospective studies examining OCD during pregnancy and postpartum period\                                                                                                                      *Original studies*\                                                                                                                                                                                                          8
  *Search:* August 2012\                                                      Incidence studies needed\                                                                                                                                                                      Small samples\                                                                                                                                                                                                               
  *\# incl. studies* 17\                                                      Course of OCD across reproductive events\                                                                                                                                                      Difficult to match control studies on various factors\                                                                                                                                                                       
  *Meta‐analysis:* yes                                                        Influence of biological determinants on OCD exacerbation throughout reproductive period                                                                                                        Possible overestimation of OCD prev in some control studies\                                                                                                                                                                 
                                                                                                                                                                                                                                                                             OCD evaluated at different pregnancy time points, making comparisons difficult\                                                                                                                                              
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Published studies                                                                                                                                                                                                            

  Molyneaux [2014](#brb3497-bib-0038){ref-type="ref"}\                        Validation of anxiety scales for specific populations needed, ex. women in early pregnancy                                                                                                     *Original*\                                                                                                                                                                                                                  6
  *Search:* Jan 2013\                                                                                                                                                                                                                                                        Heterogeneity: different screening measures and cut‐offs\                                                                                                                                                                    
  *\# incl. studies* 62\                                                                                                                                                                                                                                                     *Review*\                                                                                                                                                                                                                    
  *Meta‐analysis:* insufficient studies for meta‐a for anxiety                                                                                                                                                                                                               English language papers only\                                                                                                                                                                                                
                                                                                                                                                                                                                                                                             Published studies eligible\                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                             Few studies carried out in low and middle‐income countries                                                                                                                                                                   

  Sawyer [2010](#brb3497-bib-0044){ref-type="ref"}\                           Longitudinal studies to determine anxiety prev at different time points during and after pregnancy\                                                                                            *Original studies*\                                                                                                                                                                                                          6
  *Search:* January 2009\                                                     Develop cross‐cultural measures of mental health                                                                                                                                               Small number of studies\                                                                                                                                                                                                     
  *\# incl. studies* 35\                                                                                                                                                                                                                                                     Measurement issues, timing of mental health assessment varied (thus, anxiety trajectory over time is unclear)\                                                                                                               
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                       Few studies on antenatal mental health and associated risk factors in African women\                                                                                                                                         
                                                                                                                                                                                                                                                                             Insufficient info on how maternal psychological problems impact children\                                                                                                                                                    
                                                                                                                                                                                                                                                                             *Review* -- NR                                                                                                                                                                                                               

  *LGB and self‐harm patients*                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  King [2008](#brb3497-bib-0029){ref-type="ref"}\                             Prospective studies to determine risk factors of mental disorders\                                                                                                                             *Original studies*\                                                                                                                                                                                                          7
  *Search:* 2005\                                                             Refine definition of sexual orientation                                                                                                                                                        Difficult to recruit and define LGB group\                                                                                                                                                                                   
  *\# incl. studies* 25\                                                                                                                                                                                                                                                     Study design heterogeneity\                                                                                                                                                                                                  
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                       Heterogeneity in definitions of exposure and outcome\                                                                                                                                                                        
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             Heterogeneity: study designs and LGB definition\                                                                                                                                                                             
                                                                                                                                                                                                                                                                             Small number of studies included                                                                                                                                                                                             

  Hawton [2013](#brb3497-bib-0025){ref-type="ref"}\                           Studies on mental disorders in those who repeat self‐harm                                                                                                                                      *Original studies*\                                                                                                                                                                                                          6
  *Search:* Nov. 2011\                                                                                                                                                                                                                                                       Measurement equivalence issues\                                                                                                                                                                                              
  *\# incl. studies* 50\                                                                                                                                                                                                                                                     Heterogeneity: methods used to recruit participants, different diagnostic measures used, differences in study participant gender ratios\                                                                                     
  *Meta‐analysis:* yes                                                                                                                                                                                                                                                       cross‐sectional studies\                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                             *Review*\                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                             English language studies                                                                                                                                                                                                     
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

prev, prevalence; anx, anxiety; NR, not reported; QA, quality assessment based on AMSTAR criteria.
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